Latest

Halliburton Launches AI-Powered Agile Asset Management for Oil and Gas Investment Decisions Halliburton (NYSE: HAL) introduced Agile Asset Management, a

Halliburton (NYSE: HAL) introduced Agile Asset Management, a new AI-powered, cloud-based Landmark solution designed to help oil and gas companies evaluate field-development alternatives and...

11-03-26

Broadridge Reaffirms FY27 Outlook as Recurring Revenue Grows 11% Broadridge Financial Solutions (NYSE: BR) reported a solid start to fiscal

Broadridge Financial Solutions (NYSE: BR) reported a solid start to fiscal 2027, with double-digit recurring revenue growth and stronger closed sales, while profitability was...

11-03-26

L3Harris Receives $36 Million U.S. Army SATCOM Order for C2NOW Program L3Harris Technologies (NYSE: LHX) received a $36 million order

L3Harris Technologies (NYSE: LHX) received a $36 million order from the U.S. Army for its Hawkeye 4 Lite satellite communications terminals, supporting the military’s...

11-03-26

CrowdStrike Expands AI Security Integrations With AWS CrowdStrike (NASDAQ: CRWD) announced new integrations with Amazon Web Services designed to extend

CrowdStrike (NASDAQ: CRWD) announced new integrations with Amazon Web Services designed to extend Falcon protection across AI applications, agentic workflows and cloud infrastructure. The...

11-03-26

Tradeweb Launches Muni Sweep to Speed Municipal Bond Trading Tradeweb Markets (NASDAQ: TW) launched Muni Sweep, a new session-based trading

Tradeweb Markets (NASDAQ: TW) launched Muni Sweep, a new session-based trading protocol designed to help municipal bond market participants evaluate and trade inventory more...

11-03-26

Accenture and Kbrw Help Orange France Modernize Order Fulfillment Across Sales Channels Accenture (NYSE: ACN) and French supply chain software

Accenture (NYSE: ACN) and French supply chain software company Kbrw have been selected by Orange France to modernize the telecom operator’s order management and...

11-03-26

Snowflake Expands Agentic AI Push With CoCo and CoWork Bots Snowflake (NYSE: SNOW) unveiled a major expansion of its enterprise

Snowflake (NYSE: SNOW) unveiled a major expansion of its enterprise AI platform at Snowflake Expedition 2026, introducing new autonomous capabilities for CoCo and CoWork...

11-03-26

U.S. Job Openings and Factory Orders Beat Forecasts in September U.S. economic data came in stronger than expected in September,

U.S. economic data came in stronger than expected in September, with both job openings and factory orders exceeding market forecasts. JOLTS job openings rose...

11-03-26

Zebra Technologies Plunges 12% as Margin Compression Overshadows Strong Growth and Raised Outlook Zebra Technologies (NASDAQ: ZBRA) shares fell about

Zebra Technologies (NASDAQ: ZBRA) shares fell about 12% despite reporting strong third-quarter 2026 revenue growth, higher earnings and an increased full-year outlook. Third-quarter sales...

11-03-26

Dynatrace Plunges 15% as Strong Q2 Growth Fails to Offset Concerns Over Forward Expectations Dynatrace (NYSE: DT) shares fell about

Dynatrace (NYSE: DT) shares fell about 15% despite reporting solid second-quarter fiscal 2027 growth, strong margins and an expanded share repurchase authorization. Annual recurring...

11-03-26

BioNTech Edges Up 0.5% as Revenue Guidance Rises and Oncology Pipeline Advances BioNTech (NASDAQ: BNTX) shares rose about 0.5% after

BioNTech (NASDAQ: BNTX) shares rose about 0.5% after the company reported a return to quarterly profitability, raised the midpoint of its 2026 revenue guidance...

11-03-26

Fiserv Jumps 7% as Cost-Savings Target Doubles and Share Buybacks Resume Fiserv (NASDAQ: FISV) shares rose about 7% despite weak

Fiserv (NASDAQ: FISV) shares rose about 7% despite weak third-quarter 2026 revenue trends, as investors appeared to focus on a sharply higher cost-savings target,...

11-03-26

NASDAQ:AAPLFollow

Track all markets on TradingView - Prices are not updated in real time

Apple Falls 4.5% Premarket Despite Record Q4 Revenue as Tariff Refunds Boost Reported Margins

Apple (NASDAQ: AAPL) shares fell about 4.5% in premarket trading despite reporting record fiscal fourth-quarter 2026 revenue, iPhone sales and earnings per share.

Quarterly revenue rose 12% year over year to $114.5 billion, marking a September-quarter record. Apple also said iPhone revenue reached a September-quarter high, while Services revenue set a new all-time record.

Diluted EPS increased 14% to $2.10. Gross margin was 47.9%, but the quarter benefited from approximately 1 percentage point of favorable impact from tariff refunds. The refunds also added about $0.05 to EPS, meaning part of the reported margin and earnings strength came from a non-recurring benefit.

Apple generated $28 billion of operating cash flow during the quarter and returned $28 billion to shareholders. For the full fiscal year, revenue reached a record $479 billion, while the installed base of active devices also reached new highs across major product categories and geographic regions.

The company highlighted its new iPhone lineup, expanded home hardware portfolio and the rollout of its new Siri AI capabilities as key products heading into the holiday season.

The 4.5% premarket decline suggests investors are looking beyond the strong headline numbers. One possible concern is the quality of the margin and EPS beat, given the meaningful contribution from tariff refunds. With the press release not providing detailed forward guidance, the selloff may also reflect expectations that were already elevated ahead of the report, leaving the market focused on underlying profitability and the sustainability of growth once temporary tariff benefits are excluded.

💬 🔗

Global Finance News 11-03-26

Apple unveils groundbreaking MacBook Pro with PROLED XDR Display - Apple

Apple today introduced the all-new MacBook Pro with PROLED XDR Display featuring breakthrough tandem OLED technology.

(apple.com)

💬 🔗

Global Finance News 11-01-26

Apple Launches New Mac mini and Mac Studio With M6 and M5 Ultra Chips

Apple said its latest Mac mini and Mac Studio models are now available, expanding the company’s desktop lineup with new Apple silicon aimed at stronger AI, graphics and professional computing performance.

The new Mac mini is offered with the M6 or M5 Pro chip. Apple said the M6 version delivers up to 4x faster AI performance, 2x faster graphics and storage performance, and 40% faster CPU performance compared with the prior-generation model. The M5 Pro configuration is aimed at more demanding workloads such as video production and game development.

Mac Studio now comes with M5 Max or M5 Ultra. The M5 Ultra version supports up to a 36-core CPU, an 80-core GPU and 512GB of unified memory, while Thunderbolt 5 with RDMA support allows multiple Mac Studio systems to be clustered for distributed AI inference.

Both systems are positioned heavily around on-device AI and run macOS 27, which includes Siri AI and other Apple Intelligence features. Apple is increasingly emphasizing local AI workloads, agentic workflows and large-model inference as part of its Mac strategy.

Pricing starts at $899 for Mac mini with M6 and $2,499 for Mac Studio with M5 Max. The M5 Ultra version starts at $5,499.

💬 🔗

Global Finance News 09-22-26

The latest iPhone, Apple Watch, and AirPods lineups arrive in stores worldwide - Apple

On Friday, September 18, Apple Store locations around the world introduced customers to the iPhone 18 Pro lineup, Apple Watch Series 12, Apple Watch Ultra 4, and AirPods 5.

(apple.com)

💬 🔗

Global Finance News 09-19-26

Apple Rolls Out Siri AI Across Its Software Platforms

Apple (NASDAQ: AAPL) has begun rolling out major software updates across its ecosystem, headlined by Siri AI and the next generation of Apple Intelligence.

Siri AI is designed as a more conversational and context-aware assistant, with the ability to understand information across messages, emails and photos, recognize what is displayed on a user’s screen and perform more actions across apps. The beta is initially rolling out in English, with additional languages planned for October.

Apple is also expanding generative AI throughout its products. New capabilities include Write with Siri, AI-powered photo editing and image generation, smarter Safari tab organization and website-change alerts.

The updates are rolling out across iOS 27, iPadOS 27, macOS 27, watchOS 27, visionOS 27 and tvOS 27. However, Siri AI will initially face regional limitations, including no availability in China while Apple works through regulatory requirements.

The launch represents a major step in Apple’s effort to integrate generative AI more deeply across its hardware and software ecosystem and strengthen its position in the rapidly expanding consumer AI market.

💬 🔗

The Investor 09-15-26

Broadcom and Apple, and the End of Apple’s Run of Squeezing Suppliers? | Chip Stock Investor

💬 🔗

The Investor 09-15-26

Top Stock Market Highlights of the Week: Apple, Qualcomm, Sembcorp Industries and Mapletree Logistics Trust

We look at Apple's shift to a split iPhone launch strategy, a major AI chip partnership, and two corporate developments from Singapore-listed companies.

(thesmartinvestor.com.sg)

💬 🔗

The Investor 09-12-26

Apple unveils iPhone Duo - Apple

Apple today introduced iPhone Duo, the first foldable iPhone.

(apple.com)

💬 🔗

The Investor 09-10-26

Apple Stock in Focus as Rothschild & Co Redburn Upgrades AAPL to Buy, Sets $400 Target

Apple (NASDAQ: AAPL) shares are in focus Monday after Rothschild & Co Redburn upgraded the iPhone maker to Buy from Neutral and set a $400 price target.

Analyst Timm Schulze-Melander issued the bullish rating with Apple shares at $305.61, implying approximately 31% upside to the new target.

The upgrade comes as investor attention increasingly shifts toward Apple’s ability to monetize artificial intelligence across its enormous installed device base. Apple remains uniquely positioned within the technology sector because of the combination of its premium hardware ecosystem, high-margin Services business and ability to integrate AI capabilities directly across iPhone, Mac and other devices.

A $400 target also suggests Rothschild & Co Redburn sees room for Apple’s valuation to remain elevated as the company enters its next product and AI cycle.

The rating change is particularly notable because it represents an outright upgrade rather than simply an increase in the price target. Moving from Neutral to Buy signals a materially more constructive view of Apple’s risk-reward profile.

With AAPL trading around $305.61 in the rating report, investors will now watch whether improving expectations around AI monetization, Services growth and the broader Apple ecosystem can provide enough earnings growth to justify the analyst’s $400 target.

💬 🔗

European Investor 08-17-26

Apple Stock Falls After Jefferies Downgrade to Underperform

Apple (NASDAQ: AAPL) shares fell about 2.2% Monday after Jefferies Financial Group downgraded the iPhone maker to Underperform from Buy and sharply reduced its price target.

Jefferies analyst Edison Lee lowered the firm's price target on Apple to $263.66 from $285.56. With Apple previously trading around $306.57, the new target implies roughly 14% downside from that level.

Jefferies Turns Bearish on Apple

The downgrade represents a significant shift in Jefferies' view of Apple, moving directly from a bullish Buy recommendation to an Underperform rating rather than stepping down to Neutral.

The substantial reduction in the price target also suggests Jefferies sees Apple's current valuation as difficult to justify relative to its expectations for the company's future earnings and growth.

Monday's approximately 2.2% decline indicates investors are taking the more cautious analyst view seriously, particularly after Apple's recent share-price strength.

Why Is AAPL Stock Down Today?

The Jefferies downgrade appears to be the primary company-specific catalyst behind Monday's decline.

At approximately $306.57 before the move, Apple was trading more than $40 above Jefferies' new $263.66 target. That valuation gap provides a clear explanation for the market's negative reaction.

The downgrade also comes as investors continue to assess Apple's position in artificial intelligence and whether its AI strategy can generate sufficient new revenue and device demand to support its premium valuation.

For now, the combination of a two-notch downgrade and a substantially lower price target is putting pressure on AAPL shares, with investors likely to watch whether other Wall Street analysts become more cautious on Apple's valuation and AI-driven growth expectations.

💬 🔗

European Investor 08-10-26

Load More

11-03-26The Investor

11-03-26The Investor

11-03-26The Investor

11-03-26Global Finance News

11-03-26Global Finance News

Brent CrudeFollow

Track all markets on TradingView - Prices are not updated in real time

Brent Crude Rebounds While Gold Falls as Middle East Tensions Shift Inflation Expectations

Brent crude rose while gold moved sharply lower on Tuesday, as renewed Middle East tensions pushed energy prices higher but also strengthened concerns that inflation could remain elevated.

Brent futures climbed about 1.9% to $106.71 a barrel, reversing part of the previous session’s steep decline. The rebound followed renewed geopolitical tensions involving the U.S. and Iran, which brought supply risks back into focus after hopes for diplomatic progress had reduced the oil market’s risk premium.

Oil prices moved higher after reports of a U.S. strike on Iran’s Qeshm Island, while comments from Iranian officials suggested the two sides remain far apart on a potential agreement. The developments revived concerns over Middle East supply disruptions and restored part of the geopolitical risk premium that had been removed from prices a day earlier. (Reuters)

The move suggests traders are once again pricing in the possibility of disruptions to regional energy flows, particularly if tensions spread to shipping routes or critical oil infrastructure. Brent had fallen sharply a day earlier as expectations for negotiations increased, making Tuesday’s rebound largely a reassessment of those assumptions.

Gold moved in the opposite direction. Futures fell about 1.5% to $3,910.10 an ounce, extending pressure on bullion despite the increase in geopolitical uncertainty.

The decline appears to reflect the inflation and interest-rate implications of higher oil prices. A renewed rise in energy costs can increase inflation expectations and reinforce the case for tighter or more prolonged restrictive monetary policy. Higher interest rates and bond yields generally reduce the relative appeal of non-yielding assets such as gold.

The contrasting moves in Brent and gold highlight how the same geopolitical event can affect asset classes differently. Oil is benefiting directly from renewed supply-risk concerns, while gold is facing pressure from the possibility that higher energy prices could keep inflation and interest rates elevated.

Near-term direction for both markets is likely to remain tied to developments between Washington and Tehran. Further escalation could support crude prices, while gold may continue to depend more heavily on how the conflict affects Treasury yields, the U.S. dollar and expectations for Federal Reserve policy.

💬 🔗

Global Finance News 11-03-26

Brent Crude Falls 3.7% as Iran Peace Talks Ease Immediate Supply Fears

Brent crude fell sharply on Monday, trading around $109.21 a barrel and down about 3.7%, as renewed diplomatic efforts involving Iran and Qatari mediators reduced some of the geopolitical risk premium that had built into oil prices. (The Wall Street Journal)

The decline follows a strong October rally that pushed Brent to its highest level in roughly six months. With no major military escalation over the weekend and negotiations continuing, traders appear to be taking profits and reassessing the probability of further disruption to oil flows through the Strait of Hormuz. (business-standard*com)

However, underlying supply conditions remain tight. Regional disruptions have already depleted global inventories significantly, while diesel stocks remain unusually low in several markets. That means the current decline appears more related to a reduction in geopolitical risk premium and profit-taking than to a fundamental shift toward abundant supply. (Reuters)

The key near-term driver remains the Iran diplomatic process: meaningful progress could push more risk premium out of crude prices, while renewed military escalation could quickly reverse the current selloff.

💬 🔗

The Investor 11-02-26

Brent Crude Falls 1.8% as U.S.-Iran De-Escalation Hopes Ease Supply Fears

Brent crude fell about 1.8% to $109.68 per barrel as renewed hopes for an easing in U.S.-Iran tensions reduced some of the geopolitical risk premium that had recently pushed oil prices higher.

The move also appears to reflect profit-taking after last week’s strong rally, when concerns over Middle East supply disruptions drove crude sharply higher. Traders are now reassessing whether the recent escalation will translate into a lasting hit to oil flows.

Supply risks have not disappeared, however, and continued instability in the region is helping keep Brent elevated above $109 per barrel. That means oil prices remain sensitive to any new developments involving Iran, regional attacks or disruptions to major shipping routes.

Overall, Monday’s decline looks more like a partial unwinding of geopolitical risk premium than a major change in the underlying supply outlook.

💬 🔗

WS News 10-26-26

Brent Crude Jumps Nearly 4% as Middle East Supply Risks and U.S. Gulf Shutdowns Intensify

Brent crude futures surged 3.94% to around $104.15 per barrel on Thursday, extending gains as geopolitical and weather-related supply concerns returned to the forefront of the oil market.

The strongest catalyst is renewed disruption risk around the Strait of Hormuz and the wider Gulf. Shipping activity through Hormuz has fallen sharply following a fresh wave of tanker attacks, increasing concerns over the security of a route that handled roughly one-fifth of global oil and fuel flows before the current conflict. (Reuters)

Supply fears were compounded by production disruptions in the U.S. Gulf of Mexico. Offshore producers have curtailed operations as Hurricane Isaias approaches, temporarily removing part of U.S. oil and gas output from the market. U.S. crude inventories also fell by 3.2 million barrels, adding another supportive factor. (Reuters)

The sharp move above $104 suggests traders are rebuilding a geopolitical risk premium after recent attempts to ease supply pressure through strategic stock releases.

Near term, Brent’s direction will remain highly sensitive to tanker traffic through Hormuz, further attacks on regional energy infrastructure, the duration of Gulf of Mexico production outages and any escalation involving Iran.

💬 🔗

The Investor 10-08-26

Brent crude futures fell 1.34% to $98.98 per barrel in early trading, extending losses after briefly trading above $101 earlier in the session.

Prices moved sharply lower during the morning, slipping below the $100 level and reaching an intraday low near $99.

The move marks a notable reversal from earlier gains, with Brent giving up more than $2 per barrel from its session high.

💬 🔗

Global Finance News 10-06-26

Brent Crude Holds Above $102 After Sharp Intraday Volatility

Brent crude futures traded around $102.14 per barrel on Monday, down 0.11%, after a highly volatile early session.

Prices initially fell below $101 before rebounding sharply and briefly moving above $103 per barrel. Brent later gave back part of the advance but remained comfortably above the session’s early lows.

The price action suggests the oil market remains highly sensitive to shifting supply and geopolitical expectations. The rapid rebound from below $101 indicates buyers are still emerging aggressively on dips, while the pullback from above $103 shows resistance at higher levels.

Near term, the $103 area appears to be an important upside level, while the roughly $101–$102 range could provide support if volatility persists. The broader direction will remain heavily dependent on developments affecting global supply expectations and Middle East risk.

💬 🔗

European Investor 10-05-26

U.S. Crude Inventories Rise as Atlanta Fed GDPNow Estimate Drops to 3.7%

U.S. crude oil inventories increased by 922,000 barrels in the latest weekly report, contrary to expectations for a 700,000-barrel decline. The previous reading showed a much larger 2.969 million-barrel build.

Inventories at Cushing, Oklahoma, also rose by 553,000 barrels after increasing by 2.266 million barrels previously, adding to signs of a looser near-term crude supply balance.

Separately, the Atlanta Fed’s GDPNow estimate for third-quarter U.S. economic growth fell sharply to 3.7% from 5.0%. The previous estimate had also stood at 5.0%.

For markets, the inventory build is a negative signal for crude prices because it suggests supply exceeded expectations during the week. At the same time, the lower GDPNow estimate points to softer expected economic growth, which could further weigh on oil demand expectations while supporting expectations for a less restrictive Federal Reserve stance.

💬 🔗

Global Finance News 09-30-26

Brent Crude Rises 1.6% as U.S.-Iran Talks Stall and Hormuz Risks Persist

Brent crude futures rose 1.6% to around $99 a barrel on Monday as geopolitical risk returned to the market following another setback in U.S.-Iran negotiations.

Oil prices gained after U.S. President Donald Trump rejected Iran’s latest proposal aimed at reopening the Strait of Hormuz, while both sides remained open to further talks. The unresolved dispute has kept a geopolitical premium in crude because the waterway remains critical to Gulf oil exports.(thenationalnews*com)

At the same time, supply concerns are being partly offset by improving regional export flows. Middle East crude exports are on track to reach about 12.8 million barrels per day in September, their highest level since the conflict began, while shipments through Hormuz have also recovered significantly from earlier disruptions.(Iran International)

Saudi Arabia’s East-West pipeline has also restarted after being damaged earlier this month, providing another route for crude exports and limiting some of the upside pressure on prices. (Reuters)

The result is a highly volatile oil market: geopolitical tensions continue to support Brent, while improving Gulf exports and alternative Saudi shipping routes are preventing supply fears from escalating further.

💬 🔗

The Investor 09-28-26

Brent Crude Climbs Back Above $100 as U.S.-Iran Tensions Revive Supply Concerns

Brent crude futures rose 2.08% to $100.16 a barrel on Thursday as renewed concerns over Middle East supply risks outweighed recent optimism around improving Gulf exports.

Oil prices rebounded after hopes for a quick U.S.-Iran diplomatic breakthrough faded. Talks surrounding the UN General Assembly produced limited progress, while uncertainty remained over the reopening of the Strait of Hormuz, a critical route for global crude shipments. (The National)

The move reverses part of Brent’s recent decline. Earlier this week, prices had fallen below $100 as Saudi Arabia restarted its East-West pipeline and markets anticipated increased exports through the Red Sea, while expectations for U.S.-Iran negotiations reduced the geopolitical risk premium. (FXStreet)

Supply concerns have not disappeared, however. Restrictions around Hormuz remain a major risk, while tight refined-product markets—particularly diesel—are adding support to crude prices. (Kitco)

Near-term direction is likely to remain highly sensitive to developments between Washington and Tehran, shipping flows through Hormuz and the pace of Saudi supply normalization.

💬 🔗

European Investor 09-24-26

Brent Crude Falls 1.1% as Saudi Pipeline Restarts and Hormuz Reopening Hopes Pressure Prices

Brent crude futures fell 1.14% to around $99.20 a barrel Tuesday, extending recent weakness as improving Middle East supply prospects reduced some of the geopolitical risk premium in oil prices.

The biggest pressure came from Saudi Arabia’s East-West Pipeline. The kingdom has restarted operations after the route was shut following drone attacks, and exports from the Red Sea port of Yanbu could resume. The pipeline had been used to reroute roughly 4 million barrels per day around the Strait of Hormuz, making its restart an important development for regional supply. (Reuters)

Oil prices also weakened after Iran signaled that the Strait of Hormuz could reopen within seven days if the U.S. eases military pressure and lifts its blockade on Iranian ports. The possibility of renewed diplomacy has reduced fears of a prolonged disruption through one of the world’s most important oil transit routes. (Reuters)

At the same time, physical supply flows appear to be adapting. Middle Eastern exporters have increasingly used alternative routes and storage hubs, while Saudi shipments have remained stronger than initially feared.

Still, downside risks are not one-sided. Shipping traffic through Hormuz remains far below pre-conflict levels, and continued regional fighting means oil could remain volatile even if supply conditions improve further.

💬 🔗

WS Investor 09-22-26

Load More

11-03-26Global Finance News

11-03-26Global Finance News

11-02-26The Investor

10-15-26The Investor

10-15-26The Investor

NASDAQ:PLTRFollow

Track all markets on TradingView - Prices are not updated in real time

Palantir Falls 5% Premarket Despite Explosive Q3 Growth as Valuation and Expectations Overshadow Results

Palantir Technologies (NASDAQ: PLTR) shares fell about 5% in premarket trading despite reporting exceptionally strong third-quarter 2026 growth and raising full-year guidance above prior expectations.

Revenue surged 96% year over year to $2.31 billion and increased 20% sequentially. U.S. revenue rose 119% to $1.94 billion, while U.S. commercial revenue jumped 148% to $984 million and surpassed U.S. government revenue for the first time in company history. U.S. government revenue increased 96% to $953 million.

Profitability remained unusually strong for a company growing at this pace. GAAP operating income reached $1.08 billion, representing a 47% margin, while adjusted operating income was $1.43 billion, or a 62% margin. Adjusted free cash flow totaled $1.22 billion, equivalent to a 53% margin.

Palantir also continued to show strong deal activity, closing 212 contracts worth at least $1 million during the quarter. U.S. commercial remaining deal value increased 79% year over year to $6.52 billion.

The company raised full-year 2026 revenue guidance to $8.530-$8.534 billion and now expects U.S. commercial revenue growth of at least 143%. Adjusted operating income guidance was increased to $5.245-$5.249 billion, while adjusted free cash flow guidance rose to $4.8-$5.0 billion.

The 5% premarket decline appears to reflect the exceptionally high expectations already embedded in Palantir’s valuation rather than any obvious deterioration in fundamentals. Even with 96% revenue growth, rising margins and another guidance increase, investors may have been positioned for an even larger upside surprise. The reaction suggests that at current valuation levels, very strong results alone may not be enough to drive further gains unless growth and guidance materially exceed already aggressive expectations.

💬 🔗

Global Finance News 11-03-26

Palantir Elevates Aplos Data to Vanguard: Elite to Expand Foundry and AIP Deployments

Palantir Technologies (NASDAQ: PLTR) named Aplos Data to Vanguard: Elite, the highest tier of its trusted partner network, expanding the firm’s role from implementing Palantir for existing customers to helping bring Foundry and AIP to new customers across the United States.

The designation reflects Aplos Data’s deployment track record, with Palantir citing the company’s ability to move projects into production quickly and deliver measurable operational outcomes. Aplos was built specifically around Palantir’s platform and includes founders with prior recognition from Palantir’s developer community.

Under the expanded relationship, Aplos will support new customer acquisition as well as implementation, using its “Operate as One” methodology to integrate systems, data and decision-making into unified operating environments on Palantir.

The companies highlighted deployments at Mansfield Energy and Surf Air Mobility. At Mansfield, Aplos is helping expand the use of Foundry across operations, while at Surf Air it has supported development of SurfOS, the company’s digital infrastructure platform for aviation operations.

Aplos also demonstrated a fuel-distribution application at Palantir’s AIPCon 11 that monitors thousands of diesel tanks, predicts when fuel will run low and automatically places orders, leaving staff to intervene only on exceptions requiring human judgment.

The announcement strengthens Palantir’s partner ecosystem and could help broaden adoption of Foundry and AIP by giving new customers access to specialized implementation capacity focused exclusively on Palantir deployments.

💬 🔗

European Investor 10-22-26

Palantir Stock Rises 2.8% After Goldman Sachs and Raymond James Upgrades

Palantir shares rose about 2.8% to $199.60 after receiving two analyst upgrades, with Goldman Sachs moving the stock to Buy from Neutral and setting a $230 price target, while Raymond James upgraded shares to Outperform from Market Perform.

Goldman’s more bullish view centers on expectations that Palantir could enter another phase of outperformance into 2027. The firm sees the company’s total addressable market expanding as demand grows around sovereign AI, bespoke applications and Palantir’s verticalization strategy.(Yahoofinance)

Goldman also highlighted Palantir’s ability to connect its field engineering teams with product development, creating a feedback loop that helps customers build customized software applications and allows Palantir to scale those capabilities more efficiently.(Yahoofinance)

The stock is now trading close to its prior record high, suggesting investors are increasingly willing to pay for the prospect of another leg of growth despite Palantir’s already elevated valuation.

💬 🔗

European Investor 10-08-26

Palantir and Fujitsu Expand Partnership to Accelerate Enterprise AI Adoption

Palantir Technologies and Fujitsu have expanded their strategic partnership to accelerate enterprise AI adoption in Japan and global markets, with Fujitsu becoming a Global Forward Deployed Engineering (FDE) Partner.

Under a new agreement with Palantir Technologies Japan, Fujitsu will expand its use of Palantir’s Artificial Intelligence Platform (AIP) and Foundry while investing in FDE capabilities. The partnership will focus particularly on sovereign AI, allowing enterprises to deploy AI applications while maintaining greater control over their data, models, infrastructure and operations.

The companies highlighted an existing deployment in which Fujitsu used Palantir technology to build a supply-chain resilience system for a major Japanese manufacturer. The platform integrated information from more than 3,000 suppliers and 18 factories, generating more than $10 million in cost savings within one year while doubling operational productivity.

Fujitsu plans to combine Palantir AIP and Foundry with its own technologies, including its Takane large language model and Uvance offerings, to develop customized enterprise AI applications.

The expanded agreement builds on a strategic relationship dating to 2020 and comes as Palantir broadens its enterprise AI ecosystem.

💬 🔗

The Investor 09-10-26

NVIDIA and Palantir Partner to Bring Sovereign AI to Critical Supply Chains

NVIDIA and Palantir Technologies announced a new collaboration Thursday to develop a sovereign AI stack designed to optimize complex supply chains, with the technology initially being deployed across NVIDIA’s own operations.

The platform combines NVIDIA’s Nemotron open AI models with Palantir Foundry and its Artificial Intelligence Platform, or AIP. Grounded in Palantir’s Ontology, the system is designed to identify supply constraints, improve visibility and help organizations make operational decisions while maintaining control of proprietary data.

NVIDIA is using the technology to manage one of the semiconductor industry’s most complicated supply chains. The company said each Vera Rubin rack requires about 1.3 million parts, with production dependent on coordinated supplies of compute, memory, networking, power, cooling and mechanical components.

The companies plan to extend the technology beyond NVIDIA to industries including manufacturing, energy, healthcare, automotive and aerospace. Customers will be able to deploy the AI stack on-premises, in colocation facilities or in the cloud while retaining ownership and control of their models and operational data.

💬 🔗

The Investor 09-10-26

Palantir and Nebius Partner to Build Sovereign AI Infrastructure for Enterprise Customers

Palantir Technologies (NASDAQ: PLTR) and Nebius Group (NASDAQ: NBIS) announced a strategic partnership aimed at giving Palantir’s commercial customers greater control over the infrastructure, data and models powering their artificial intelligence applications.

Under the agreement, Palantir named Nebius its preferred sovereign AI infrastructure partner. Following an integration period, Nebius compute infrastructure and inference endpoints will be brought inside the Palantir enterprise perimeter, allowing eligible customers to access Nebius cloud and AI infrastructure directly through Palantir’s ecosystem.

The partnership combines Nebius’ AI-native computing platform with Palantir’s Sovereign AI Operating System, which incorporates AIP, Ontology, Foundry and Apollo. Customers will be able to deploy open AI models on Nebius infrastructure and continuously adapt those models using proprietary organizational data while retaining control over their compute, models and information.

The companies also plan to accelerate the deployment of additional AI computing capacity, including modular data centers at locations where power infrastructure is already available. The approach could help address one of the major constraints facing the AI industry: rapidly bringing additional computing capacity online.

For Palantir, the partnership expands the infrastructure available behind its enterprise AI platform. For Nebius, becoming Palantir’s preferred sovereign AI infrastructure partner provides another channel for its rapidly expanding AI cloud and compute business as enterprises increase spending on AI infrastructure.

💬 🔗

The Investor 09-08-26

Palantir and PwC Expand Alliance to Scale Enterprise AI

Palantir Technologies (NASDAQ: PLTR) and PwC US have expanded their strategic alliance to help companies deploy artificial intelligence across core business operations, with an initial focus on enterprise AI, mergers and acquisitions, and ERP modernization.

The collaboration combines Palantir’s Foundry and Artificial Intelligence Platform (AIP) with PwC’s consulting, engineering and industry expertise. The companies aim to help enterprises move AI projects from pilots into production and embed AI into areas such as supply chains, logistics, cybersecurity and customer management.

AI-Native M&A and ERP Transformation

A major part of the expanded partnership is a new AI-native deals IT platform powered by Palantir Foundry and AIP. PwC and Palantir said the platform is designed to help companies execute M&A transactions up to 50% faster while reducing one-time transaction costs by as much as 45%.

The companies will also use Palantir’s AI technology alongside PwC’s SAP expertise to improve data quality and reduce risks during ERP transformations.

For Palantir, the expanded PwC relationship could broaden enterprise adoption of its AI software by combining its technology with PwC’s large corporate client base and implementation capabilities. The agreement also strengthens Palantir’s position in the growing enterprise AI market, where companies are increasingly shifting from experimental AI projects toward production-scale deployments.

💬 🔗

The Investor 09-04-26

Palantir Wins U.S. Army Contract to Deliver Eight AI-Powered TITAN Systems

Palantir Technologies (NASDAQ: PLTR) has secured a new U.S. Army contract to produce and deliver eight Tactical Intelligence Targeting Access Node, or TITAN, systems, expanding the company’s role in the military’s deployment of artificial intelligence and next-generation battlefield intelligence technology.

The agreement, awarded by Army Contracting Command to Palantir’s USG subsidiary, covers four Advanced and four Basic TITAN systems. The Advanced version provides greater processing and integration capabilities, while the Basic version is designed for mobility and rapid deployment. Financial terms of the contract were not disclosed.

TITAN is an AI- and machine learning-enabled ground station designed to process data from space, high-altitude, aerial and terrestrial sensors. The system converts that information into actionable targeting intelligence that can support mission command and long-range precision fires.

Palantir will serve as the prime contractor, overseeing manufacturing and delivery of the complete systems while providing the software that powers TITAN. The platform also integrates technologies from defense and technology partners including Anduril Industries, L3Harris Technologies, Sierra Nevada Corporation, Strategic Technology Consulting and World Wide Technology.

The new award moves TITAN beyond its earlier prototype phase and further into production and operational deployment. Palantir will also continue supporting TITAN prototype systems already fielded with Army units while developing future capabilities.

The contract reinforces Palantir’s growing position at the intersection of AI, defense software and battlefield data integration. TITAN is particularly significant because Palantir is not simply supplying analytics software but acting as the prime contractor for an integrated hardware-and-software military system, potentially expanding the scope of opportunities available to the company within the U.S. defense sector.

💬 🔗

The Investor 09-02-26

Palantir Stock Soars 23% After Blowout Q2 Results and Massive Guidance Increase

Palantir Technologies (NASDAQ: PLTR) surged 23% on Tuesday after delivering another blockbuster quarterly report that significantly exceeded Wall Street expectations. The AI software company reported explosive revenue growth, record commercial demand and sharply raised its full-year outlook, reinforcing its position as one of the biggest beneficiaries of accelerating enterprise AI adoption.

Second-quarter revenue jumped 93% year over year to $1.94 billion, while U.S. commercial revenue surged an extraordinary 149% to $764 million. Total U.S. revenue climbed 115% to $1.57 billion, supported by continued strength across both commercial and government customers.

U.S. Commercial Business Continues to Accelerate

The company's commercial momentum remained the key highlight of the quarter. Palantir closed a record $2.13 billion in U.S. commercial total contract value (TCV), up 153% from a year ago, while U.S. commercial remaining deal value increased 124% to $6.24 billion.

Overall, the company closed 220 deals worth at least $1 million during the quarter, including 73 contracts exceeding $10 million. Total contract value reached $3.37 billion, up 49% year over year, highlighting sustained demand for Palantir's AI-driven software platform.

CEO Alex Karp said growing demand for "AI sovereignty" is driving organizations toward platforms that allow customers to retain full control of their data while deploying artificial intelligence at scale.

Profitability and Cash Flow Reach New Highs

Palantir also demonstrated exceptional profitability alongside its rapid growth. GAAP operating income reached $912 million, representing a 47% operating margin, while adjusted operating income climbed to $1.19 billion, or 62% of revenue.

GAAP net income totaled $1.06 billion, with both adjusted free cash flow and cash from operations exceeding $1.2 billion. The company ended the quarter with $9.2 billion in cash, cash equivalents and short-term U.S. Treasury securities, providing significant financial flexibility.

Guidance Raised Well Above Expectations

Management substantially increased its 2026 outlook, now expecting full-year revenue between $8.15 billion and $8.16 billion, representing approximately 82% annual growth. The company also raised its U.S. commercial revenue forecast to more than $3.42 billion, implying at least 134% growth, while increasing adjusted operating income guidance to as much as $4.90 billion.

## What to Watch

Tuesday's rally reflects investor confidence that Palantir remains one of the strongest AI growth stories in the market. Investors will now focus on whether the company can sustain its exceptional commercial growth, continue converting large enterprise contracts into recurring revenue, and maintain its industry-leading profitability as AI adoption accelerates globally.

💬 🔗

European Investor 08-04-26

Palantir (PLTR) Stock Rises After DA Davidson Upgrades Shares to Buy

Palantir Technologies (NASDAQ: PLTR) shares gained approximately 3.5% on Thursday after DA Davidson upgraded the software company to Buy from Neutral and raised its price target to $175 from $165.

The upgrade comes as Palantir continues to benefit from strong investor enthusiasm surrounding artificial intelligence, with the company expanding its presence across both commercial and government markets through its AI-driven software platforms.

DA Davidson upgraded the stock and increased its price target, reflecting a more constructive outlook on the shares. The positive analyst action added to investor optimism surrounding Palantir's long-term growth potential.

Palantir has been one of the strongest performers in the software sector this year as enterprises continue increasing investments in AI applications, data analytics, and automation. The company has also continued to win government contracts while expanding adoption of its Artificial Intelligence Platform (AIP) among commercial customers.

# Why PLTR Stock Rose

Several factors supported the stock:

* DA Davidson upgraded Palantir to Buy from Neutral.
* The firm raised its price target to $175 from $165.
* Continued optimism around enterprise AI adoption and government demand has supported investor sentiment toward Palantir.
* The company remains well positioned to benefit from growing investment in AI-powered software and data analytics.

The combination of a rating upgrade and continued optimism surrounding the AI sector helped lift Palantir shares approximately 3.5% during Thursday's trading session.

💬 🔗

Global Finance News 07-02-26

Load More

11-03-26The Investor

11-03-26Global Finance News

10-09-26WS News

10-08-26European Investor

10-08-26European Investor

NYSE:YUMFollow

Track all markets on TradingView - Prices are not updated in real time

Yum! Brands Edges Up 0.4% as KFC Growth and Pizza Hut Divestiture Support Outlook

Yum! Brands (NYSE: YUM) shares rose about 0.4% after the company reported third-quarter 2026 results highlighted by strong KFC expansion, completion of the Pizza Hut divestiture and continued capital returns.

Third-quarter GAAP EPS was $5.92, boosted by an approximately $1.7 billion pre-tax gain related to the sale of Pizza Hut. EPS excluding special items was $1.56.

Excluding Pizza Hut, Yum! increased its unit count by 7%, including 955 gross new openings during the quarter. KFC remained the strongest contributor, with system sales up 6%, same-store sales up 1% and unit growth of 7%. KFC core operating profit increased 8%.

Taco Bell delivered a softer quarter, with system sales down 2% and same-store sales down 4%, while core operating profit declined 4%. However, management said Taco Bell U.S. has been outperforming the broader quick-service restaurant industry on same-store sales growth since the end of September.

Digital sales remained an important growth driver, exceeding $9 billion during the quarter and representing 64% of system sales.

Yum! also returned $1.8 billion to shareholders through dividends and share repurchases year to date. Following the completion of the Pizza Hut divestiture, management is focusing the portfolio more heavily on KFC and Taco Bell.

The modest 0.4% gain appears to reflect a mixed operating picture. KFC’s strong development, portfolio simplification and continued shareholder returns were supportive, but weaker Taco Bell same-store sales and only 1% quarterly core operating profit growth excluding Pizza Hut limited the upside.

💬 🔗

The Investor 11-03-26

Yum! Brands Completes $2.7 Billion Pizza Hut Sale, Sharpens Focus on KFC and Taco Bell

Yum! Brands (NYSE: YUM) has completed the sale of its Pizza Hut business outside mainland China to private equity firm LongRange Capital for approximately $1.5 billion, marking the final step in the restaurant group’s exit from the global Pizza Hut business. Yum! could also receive an additional $75 million earn-out by 2030 depending on future performance.

The transaction follows the previously announced sale of Pizza Hut’s mainland China operations to Yum China Holdings, which closed on August 7. Combined, the two transactions value Yum!’s divestiture of Pizza Hut at approximately $2.7 billion, subject to purchase-price adjustments.

The sale significantly reshapes Yum!’s portfolio. Following the divestiture, the company’s restaurant brands consist of KFC, Taco Bell and Habit Burger & Grill, which together operate or franchise more than 44,000 restaurants across 151 countries and territories.

Yum! said the transaction allows it to move forward as a more focused company, concentrating resources on global growth, restaurant economics, digital capabilities and its Byte by Yum! technology platform. The strategy puts greater emphasis on KFC and Taco Bell, the company’s two largest global brands.

For investors, the $2.7 billion Pizza Hut exit represents a major portfolio simplification. By removing Pizza Hut, Yum! can concentrate capital and management attention on brands with stronger strategic positioning while continuing to expand its digital and technology infrastructure. The transaction also provides substantial proceeds that increase the company’s financial flexibility as it pursues its next phase of growth.

💬 🔗

The Investor 09-02-26

Yum! Brands Stock Rallies on Strong Q2 Results and Pizza Hut Divestiture

Yum! Brands (NYSE: YUM) shares rose 4% in premarket trading after the restaurant operator reported strong second-quarter results, fueled by robust Taco Bell performance, continued global unit expansion and strategic progress toward becoming a more focused business following the sale of Pizza Hut.

Second-quarter adjusted EPS increased 12% year over year to $1.62, while worldwide system sales grew 5% excluding currency effects. The company expanded its global footprint by 1,053 gross new restaurants during the quarter, lifting total unit count by 5%. Core operating profit also increased 5%, supported by higher sales and continued margin strength across the portfolio.

Taco Bell Leads Another Strong Quarter

Taco Bell remained Yum!'s strongest growth engine, with system sales rising 9% and same-store sales increasing 7%. Operating profit jumped 19% as the brand continued to attract customers in both the U.S. and international markets.

KFC also delivered solid results, posting 6% system sales growth and opening 660 new restaurants across 55 countries. The division benefited from continued global expansion and the rollout of its refreshed brand strategy centered on boneless chicken and menu innovation.

Excluding Pizza Hut, Yum!'s digital system sales approached $9 billion during the quarter, with digital orders accounting for more than 60% of system sales, highlighting the company's continued investment in technology and customer engagement.

Pizza Hut Sale Reshapes the Portfolio

During the quarter, Yum! reached definitive agreements to sell Pizza Hut. The international Pizza Hut business will be acquired by LongRange Capital, while Yum China will purchase the Mainland China operations.

Management said the transactions conclude the strategic review process and position Yum! to become a more focused company centered on accelerating growth across its remaining brands. The company also emphasized continued investment in its Byte by Yum! digital platform to improve restaurant economics and enhance long-term shareholder value.

What to Watch

Investors welcomed the combination of accelerating same-store sales, continued global expansion and the strategic simplification of Yum!'s brand portfolio. Going forward, markets will focus on the completion of the Pizza Hut transactions, the continued momentum at Taco Bell and KFC, and whether the company's technology investments can sustain strong digital growth and restaurant profitability.

💬 🔗

WS Investor 07-30-26

Byte by Yum! Drives Higher Customer Satisfaction and Digital Sales at Yum! Brands

Yum! Brands reported that its proprietary restaurant technology platform, Byte by Yum!™, is delivering measurable improvements in customer satisfaction, operational efficiency, and digital sales across its global brands, including KFC, Taco Bell, Pizza Hut, and Habit Burger & Grill.

The Byte by Yum! platform consists of AI-driven SaaS products designed to streamline restaurant operations. Key tools include Byte Inventory, which uses real-time, AI-powered forecasting to manage stock more efficiently, and Byte Coach, which optimizes daily operations by integrating sales forecasts, customer feedback, and best-practice routines. Byte Inventory is currently deployed in around 80% of U.S. Taco Bell locations, with broader rollout planned across Yum! brands by 2026, while Byte Coach is active in nearly 30,000 KFC and Pizza Hut restaurants worldwide. In some markets, Byte Coach has contributed to customer satisfaction improvements of up to 10%.

These technologies are supported by Yum!’s proprietary Crave AI platform and a strategic partnership with NVIDIA to power AI agents within the Byte ecosystem. As a result, Yum! reported more than $30 billion in digital sales in 2024, with 2025 on track to exceed that level. In the third quarter of 2025 alone, digital system sales surpassed $10 billion, representing a record digital mix of 60%. More than 25,000 restaurants globally now use at least one Byte by Yum! product.

💬 🔗

WS Investor 12-20-25

Pizza Hut’s BOOK IT! Program Still Inspiring Young Readers After 41 Years

Yum! Brands highlights the enduring impact of Pizza Hut’s BOOK IT! program, which has encouraged more than 70 million children to develop a love of reading since 1984 by rewarding reading goals with a free Personal Pan Pizza.

In an interview, Prisma Garcia — associate manager of BOOK IT! and a former participant — shared her personal connection to the program, saying it not only motivated her to read but also created special family memories.

BOOK IT! continues to reach new generations through both traditional schools and homeschool options, and in 2025 expanded with a redesigned website and mobile app to make tracking progress and rewards easier.

Created by a former Pizza Hut president to motivate his son to read, BOOK IT! has become the largest and longest-running corporate-sponsored reading program in the U.S., reinforcing Pizza Hut’s commitment to learning, connection and community.

💬 🔗

WS Investor 11-20-25

Yum! Brands Reports Strong Q3 2025; Begins Strategic Review of Pizza Hut

Yum! Brands, Inc. (NYSE: YUM) posted solid third-quarter 2025 results, highlighted by continued growth at Taco Bell and KFC and the launch of a strategic review for Pizza Hut. GAAP EPS was $1.41, while adjusted EPS excluding special items rose 15% year over year to $1.58.

Worldwide system sales increased 5% excluding currency effects, driven by Taco Bell’s 9% growth and KFC’s 6% expansion. Global unit count grew 3% with 1,131 new openings, while digital system sales hit a record $10 billion, representing about 60% of total system sales.

New CEO Chris Turner outlined three key priorities for the company: engaging the next generation of consumers, leveraging global scale to improve franchisee economics, and expanding the Byte digital platform across more restaurants.

As part of its strategic initiatives, Yum! announced a review of strategic options for Pizza Hut aimed at maximizing long-term value creation. Turner said the brand’s strong global footprint and franchise network position it well to “reclaim leadership in the fragmented pizza category.”

Yum! also plans to acquire 128 Taco Bell restaurants in the U.S. Southeast during Q4, expanding its equity-owned base and supporting operating profit growth. The company named Ranjith Roy as its new CFO, Sean Tresvant as Taco Bell CEO and Yum! Chief Consumer Officer, and Jim Dausch as Chief Digital & Technology Officer and President of Byte by Yum!.

With robust performance across its core brands and record digital engagement, Yum! enters the final quarter of 2025 well positioned for continued growth and shareholder value creation.

💬 🔗

WS Investor 11-04-25

Taco Bell, part of Yum! Brands (NYSE: YUM), is expanding its new Live Más Café concept, with 30 additional locations set to open by the end of 2025.

The cafés, first launched in December 2024, focus on premium, specialty beverages such as Refrescas, specialty coffees, and Churro Chillers. Each operates as a “shop-within-a-shop” inside Taco Bell restaurants, staffed by dedicated “Bellristas” who provide a more handcrafted, café-style experience.
The concept was inspired by the fast-growing U.S. nonalcoholic beverage market (valued at $169.5 billion in 2024, with specialty coffees making up more than 25%). Early results exceeded expectations: sales at the first Live Más Café were four times above forecasts within two weeks of opening.

By positioning beverages as a core attraction, not just an add-on to tacos and Crunchwraps, Taco Bell aims to broaden daypart usage, capture new traffic, and increase average check sizes. With early success in California and Texas, the concept is being positioned as a premium growth driver for the brand’s future.

💬 🔗

The Investor 09-13-25

Yum! Brands to refinance Taco Bell securitized notes

Yum! Brands, Inc. (NYSE: YUM) announced its intention to refinance its Series 2016-1 Class A-2-III Fixed Rate Senior Secured Notes, issued through a subsidiary of Taco Bell under the company’s securitization financing facility backed by U.S. franchise royalties.

As of June 30, 2025, outstanding balances across the securitization facility included $938 million of the 2016-1 Class A-2-III Notes, $595 million of the 2018-1 Class A-2-II Notes, $884 million of the 2021-1 Class A-2-I Notes, $590 million of the 2021-1 Class A-2-II Notes, and $737 million of the 2021-1 Class A-2-III Notes.

The refinancing is expected to involve $1.0 billion of new senior term notes, with proceeds used to repay the 2016-1 Class A-2-III Notes, cover related expenses, and support general corporate purposes. Other series under the facility will remain outstanding.
The timing, interest rate, and completion of the refinancing remain subject to market conditions.

💬 🔗

Global Finance News 09-04-25

Yum! Brands has announced that Chris Turner will become Chief Executive Officer effective October 1, 2025, succeeding current CEO David Gibbs, who will stay on as an adviser through 2026. Turner, currently the company’s Chief Financial & Franchise Officer, has played a key role in digital transformation efforts and global franchise initiatives, including the development of Byte by Yum! and Saucy by KFC.

Gibbs, who served as CEO since 2020 and has been with the company for 37 years, led Yum! through the COVID-19 pandemic and drove major growth in digital sales and new restaurant openings. The board expressed strong confidence in Turner’s leadership to advance Yum!’s growth and innovation strategies across its global portfolio, which includes KFC, Taco Bell, Pizza Hut, and Habit Burger & Grill.

💬 🔗

WS Investor 06-18-25

Yum! Brands Q1 2025 Earnings

Yum! Brands reported solid growth in Q1 2025, led by Taco Bell and KFC International, despite challenges at Pizza Hut and a one-time tax charge.

Key Financial Highlights:
- Revenue: $1.79 billion (up 12%)
- GAAP Operating Profit: $548 million (up 5%)
- Core Operating Profit: $586 million (up 8%)
- GAAP EPS: $0.90 (down 18% year-over-year)
- EPS excluding Special Items: $1.30 (up 13%)
- Net Income: $253 million (down 19%)
- Digital system sales: approximately $9 billion (around 55% of system sales)

Segment Performance:

Taco Bell
- Same-store sales (U.S.): up 9%
- Operating profit: $241 million (up 16%)
- Operating margin: 36.7% (up 1.9 percentage points)
- System sales growth: up 11%
- Unit growth: 2%
- Continued strong innovation and domestic strength supported performance

KFC
- Same-store sales (International): up 3%
- Operating profit: $331 million (up 6%)
- System sales growth: up 5% (International: up 6%, U.S.: down 2%)
- Unit growth: 6% with 528 gross new restaurants opened
- Margin impacted by seasonal weakness and added maintenance in UK stores acquired in 2024

Pizza Hut
- Same-store sales: down 2% (U.S.: down 5%)
- Operating profit: $74 million (down 20%)
- System sales growth: down 3%
- Franchise transitions and tech expense timing contributed to profit decline

Habit Burger & Grill
- Same-store sales: down 3%
- Operating loss: $1 million
- System sales flat; 1 store opened

Strategic and Corporate Developments:
- Announced collaboration with NVIDIA to integrate AI across global restaurant operations
- CEO David Gibbs to retire in Q1 2026 after 36 years at the company
- Taco Bell presented its R.I.N.G. The Bell plan and 2025 product pipeline at Consumer Day
- Long-term targets: 5% unit growth, 7% system sales growth (ex-FX), and at least 8% core operating profit growth (ex-FX)

Balance Sheet and Cash Flow:
- Cash and cash equivalents: $607 million
- Long-term debt: $11.3 billion
- Operating cash flow: $404 million
- $229 million spent on share repurchases and $198 million on dividends

Challenges and One-Time Impacts:
- $86 million tax expense from a foreign audit in Mexico significantly impacted GAAP net income and EPS
- Company restaurant margin declined to 14.3% from 15.6%, due to lower KFC and Pizza Hut margins

💬 🔗

WS Investor 05-01-25

Load More

06-16-26Global Finance News

NASDAQ:BNTXFollow

Track all markets on TradingView - Prices are not updated in real time

BioNTech Edges Up 0.5% as Revenue Guidance Rises and Oncology Pipeline Advances

BioNTech (NASDAQ: BNTX) shares rose about 0.5% after the company reported a return to quarterly profitability, raised the midpoint of its 2026 revenue guidance and highlighted further progress across its oncology pipeline.

Third-quarter revenue was €1.29 billion, down from €1.52 billion a year earlier as expected lower demand for COVID-19 vaccines continued to weigh on sales. However, BioNTech reported net profit of €184.5 million, or €0.73 per diluted share, compared with a €28.7 million loss a year earlier.

Adjusted net profit was €440.9 million, although this was below €752.5 million in the prior-year quarter. Adjusted diluted EPS declined to €1.76 from €3.11. R&D spending increased as BioNTech continued investing in late-stage immuno-oncology and antibody-drug conjugate programs.

The company raised its full-year revenue guidance to €1.7 billion-€1.9 billion from €1.6 billion-€1.9 billion, lifting the midpoint while leaving its adjusted R&D and SG&A spending forecasts unchanged.

Pipeline progress remained central to the investment case. BioNTech reported encouraging data for pumitamig combinations in lung cancer, advanced a Phase 3 trial involving pumitamig and Gilead’s sacituzumab govitecan in triple-negative breast cancer, and said gotistobart nearly doubled median overall survival versus chemotherapy in previously treated squamous non-small cell lung cancer.

BioNTech also maintained a substantial financial cushion, ending September with €16.2 billion in cash, cash equivalents and security investments. The company has additionally repurchased about $463 million of shares under its $1 billion buyback program.

The modest 0.5% gain appears to reflect a balance between improving guidance and oncology progress on one side and declining COVID-related revenue and higher development spending on the other. With a large cash position and several late-stage oncology programs advancing, investor attention is increasingly shifting from the declining vaccine business toward BioNTech’s ability to build a diversified cancer portfolio.

💬 🔗

The Investor 11-03-26

BioNTech Stock Falls 3.1% as Argus Initiates Coverage With Hold Rating

BioNTech shares fell 3.1% to $92.27 after Argus initiated coverage of the stock with a Hold rating.

The cautious initiation likely reflects a balanced view of BioNTech’s long-term oncology potential against near-term execution and commercialization risks. The company continues to invest heavily in cancer vaccines, antibody-drug conjugates and other oncology programs as it works to diversify beyond its COVID-19 vaccine franchise.

Uncertainty around the timing and probability of success across BioNTech’s late-stage pipeline, high research and development spending, and the need for newer products to offset the decline in pandemic-related revenue might be the reason of hold rating.

The stock’s decline suggests investors are reacting negatively to the neutral rating, with Argus apparently viewing the current risk-reward profile as balanced rather than compelling enough for a Buy recommendation.

💬 🔗

European Investor 10-08-26

BioNTech Stock Falls 4.9% as BMO Capital Downgrades Shares and Cuts Price Target

BioNTech (NASDAQ: BNTX) shares fell 4.9% Tuesday after BMO Capital Markets downgraded the biotechnology company and significantly reduced its price target.

BMO Capital downgraded BioNTech from Outperform to Market Perform and cut its price target to $105 from $128.

BioNTech shares were trading around $98.69, leaving the new $105 target only about 6% above the current market price. By comparison, the previous $128 target represented substantially greater upside.

The downgrade marks a notable shift in BMO’s view of the stock. Moving from Outperform to Market Perform indicates reduced expectations for BioNTech to outperform the broader market, while the $23 reduction in the price target further reflects the analyst’s more cautious assessment.

With BNTX shares down nearly 5% following the rating action, investors will be watching the company’s oncology pipeline and other clinical developments for potential catalysts that could improve its longer-term growth outlook.

💬 🔗

The Investor 09-08-26

Pfizer and BioNTech Win FDA Approval for Updated XFG COVID-19 Vaccine

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) received U.S. FDA approval for their updated 2026–2027 COMIRNATY COVID-19 vaccine targeting the XFG variant.

The updated vaccine is approved for adults aged 65 and older and for people aged 5 to 64 who have at least one underlying condition that increases their risk of severe COVID-19. The XFG formulation follows FDA guidance aimed at more closely matching currently circulating variants.

According to the companies, supporting data showed strong immune responses against several circulating SARS-CoV-2 variants, including XFG, XFG.1.1, NB.1.8.1, PQ.17 and PQ.2.8.1. Pfizer and BioNTech said shipments will begin immediately, with the vaccine expected to reach U.S. pharmacies, hospitals and clinics within days.

The approval is commercially positive for both companies because it keeps their COVID-19 vaccine franchise positioned for the upcoming U.S. vaccination season. However, the financial impact will ultimately depend on vaccination rates and demand for updated COVID-19 shots.

💬 🔗

European Investor 08-28-26

BioNTech and Moderna: Two mRNA Giants Chart Different Paths as COVID Revenue Fades

May 6, 2026 · Earnings Analysis

The two companies that changed the world with their mRNA COVID-19 vaccines are now deep into a painful reinvention. BioNTech and Moderna both reported first quarter 2026 results within days of each other, and while the headline numbers tell a familiar story of declining vaccine revenues and widening losses, a closer look reveals two very different bets on what comes next.

BioNTech posted Q1 revenues of €118.1 million, down from €182.8 million a year ago, with net loss widening to €531.9 million. Moderna reported $389 million in revenue, up significantly from the prior year but heavily supported by international government deliveries. Moderna's net loss of $1.3 billion was inflated by a $0.9 billion one-time litigation charge, making its underlying trajectory somewhat less alarming than the headline implies. BioNTech ended the quarter with €16.8 billion in cash while Moderna held $7.5 billion.

Where the two companies diverge most sharply is strategy. BioNTech has made oncology its singular focus, pouring resources into pumitamig, gotistobart, and a growing antibody-drug conjugate portfolio, with six late-stage data readouts expected in 2026. Moderna is playing a broader game, advancing infectious disease vaccines including the world's first approved flu plus COVID combination product, while also pursuing oncology and rare disease therapeutics. Its personalized cancer vaccine intismeran, developed with Merck, will present five-year melanoma data at ASCO in June.

BioNTech is also navigating a manufacturing restructuring affecting 1,860 jobs and the planned departure of its co-founders by end of 2026. Moderna, by contrast, is cutting costs aggressively, with R&D spending down 24% year-over-year.

Both are burning cash to fund their futures. BioNTech is going deep and narrow on cancer. Moderna is going wide across multiple disease areas. Which approach pays off will likely become clearer before the year is out.

💬 🔗

WS Investor 05-06-26

BioNTech Extends Losses in Premarket as COVID Revenue Decline Widens Net Loss

May 6, 2026 · Earnings Report

BioNTech shares fell 2.66% in premarket trading today, extending a 3.88% decline from the prior session, as the German biotech reported a deepening net loss in the first quarter of 2026 driven by shrinking COVID-19 vaccine revenues.

First quarter revenues came in at €118.1 million, down from €182.8 million a year ago, with net loss widening to €531.9 million from €415.8 million in Q1 2025. Diluted loss per share was €2.10 compared to €1.73 a year ago. Despite the losses, BioNTech maintained a strong cash position of €16.8 billion and announced a share repurchase program of up to $1.0 billion over the next twelve months.

Alongside the results, BioNTech announced plans to exit manufacturing sites in Idar-Oberstein, Marburg, Singapore and CureVac facilities, affecting approximately 1,860 positions. The restructuring is expected to generate around €500 million in annual recurring savings once fully implemented in 2029. The company also confirmed that co-founders Prof. Ugur Sahin and Prof. Ozlem Tureci will transition out by end of 2026 to lead a new independent mRNA company, with a successor search now underway.

On the pipeline front, five additional pivotal trials for cancer drug pumitamig were initiated during the quarter, with key data readouts expected throughout 2026. BioNTech reaffirmed its full year revenue guidance of €2.0 billion to €2.3 billion.

💬 🔗

WS Investor 05-06-26

BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026

💬 🔗

The Investor 04-21-26

BioNTech announced positive Phase 2 trial results for its experimental cancer therapy trastuzumab pamirtecan, developed in partnership with DualityBio, showing promising efficacy in patients with advanced, HER2-expressing endometrial cancer.

In the study, the antibody-drug conjugate achieved a confirmed objective response rate of approximately 48% among evaluable patients, with median progression-free survival of about 8 months. The treatment demonstrated consistent antitumor activity across all HER2 expression levels, including patients previously treated with checkpoint inhibitors.

The trial, involving 145 heavily pre-treated patients, also showed a manageable safety profile, with most adverse effects being low-grade and consistent with similar therapies.

The results, presented at the 2026 Society of Gynecologic Oncology Annual Meeting, highlight the drug’s potential to address a significant unmet need in endometrial cancer, where current treatment options remain limited.

BioNTech plans to advance the therapy into ongoing Phase 3 trials and is targeting a regulatory filing in 2026, subject to feedback from the U.S. Food and Drug Administration.

💬 🔗

Global Finance News 04-13-26

BioNTech announced new clinical data from its late-stage lung cancer portfolio to be presented at ELCC 2026, highlighting progress across multiple therapeutic approaches.

Updated results for pumitamig, a bispecific immunomodulator, reinforced its efficacy and safety profile, while Phase 3 data for gotistobart showed meaningful survival benefits compared to standard treatments in advanced lung cancer.

The company also emphasized advances in antibody-drug conjugates and mRNA-based therapies, supporting its strategy to develop differentiated, combination-driven treatments across all stages of lung cancer.

💬 🔗

Global Finance News 03-24-26

BioNTech reported full-year 2025 revenue of €2.9 billion and a net loss of €1.1 billion while maintaining a strong financial position with €17.2 billion in cash and investments. The company expects 2026 revenue of €2.0–€2.3 billion and plans significant R&D spending as it advances its oncology pipeline, including immunomodulators, antibody-drug conjugates and mRNA cancer therapies. BioNTech anticipates a catalyst-rich year in 2026 with six late-stage clinical data readouts and continued progress toward its goal of becoming a multi-product biopharmaceutical company by 2030.
Source: Globe Newswire

💬 🔗

European Investor 03-10-26

Load More

NASDAQ:VRTXFollow

Track all markets on TradingView - Prices are not updated in real time

Vertex Pharmaceuticals Edges Up 0.3% Premarket as Revenue Growth and Higher Guidance Offset Acquisition Costs

Vertex Pharmaceuticals (NASDAQ: VRTX) shares rose about 0.3% in premarket trading after the company reported solid third-quarter 2026 revenue growth and raised its full-year sales outlook, while higher expenses tied to the Crinetics acquisition limited the market reaction.

Third-quarter revenue increased 12% year over year to $3.44 billion. U.S. revenue rose 10% to $2.17 billion, supported by continued cystic fibrosis demand, including ALYFTREK uptake, as well as contributions from CASGEVY, JOURNAVX and PALSONIFY. International revenue increased 16% to $1.27 billion.

GAAP net income fell to $654 million from $1.1 billion a year earlier, largely because of costs related to the Crinetics Pharmaceuticals acquisition. Non-GAAP net income remained roughly flat at $1.2 billion as higher product revenue was offset by increased operating expenses, higher interest expense and lower interest income.

Vertex raised its 2026 revenue guidance to $13.15 billion-$13.25 billion from $13.1 billion-$13.2 billion. The outlook includes at least $500 million of combined revenue from CASGEVY and JOURNAVX and $40 million-$50 million from PALSONIFY.

At the same time, expense guidance increased materially. Combined GAAP R&D, acquired IPR&D and SG&A expense guidance rose to $7.15 billion-$7.2 billion from $6.3 billion-$6.45 billion, primarily reflecting Crinetics integration and operating costs. Non-GAAP expense guidance also increased to about $6.0 billion.

The modest 0.3% premarket gain appears to reflect a balance between strong top-line growth, higher revenue guidance and continued portfolio diversification on one side, and acquisition-related costs and rising operating expenses on the other. Investors are also likely watching the November 30 PDUFA date for povetacicept, which could establish renal medicine as Vertex’s next major commercial franchise.

💬 🔗

Global Finance News 11-03-26

Vertex Completes $10 Billion Crinetics Acquisition, Expanding Into Rare Endocrine Diseases

Vertex Pharmaceuticals (NASDAQ: VRTX) announced Tuesday that it has completed its acquisition of Crinetics Pharmaceuticals, adding a new rare endocrine disease business to its growing portfolio beyond cystic fibrosis.

The transaction values Crinetics at approximately $10 billion in equity value, or about $8.8 billion after accounting for estimated cash acquired. Vertex expects the acquisition to accelerate revenue growth and become accretive to non-GAAP operating income in 2029.

The centerpiece of the deal is PALSONIFY, the first and only once-daily oral therapy for acromegaly. The drug has already launched in the U.S., received approval in Europe and is under regulatory review in additional markets.

Vertex also gains atumelnant, a once-daily oral ACTH receptor antagonist currently in Phase 3 development for congenital adrenal hyperplasia and Phase 2 development for Cushing’s syndrome. Vertex estimates that PALSONIFY and atumelnant could generate more than $5 billion in combined annual revenue at peak.

The acquisition establishes rare endocrine diseases as another major growth pillar for Vertex alongside cystic fibrosis, hematology, acute pain and renal diseases. It also reduces the company’s historical dependence on its highly successful cystic fibrosis franchise.

Vertex separately announced several leadership changes to support its expanding portfolio. Charles Wagner will oversee the Crinetics integration as COO, Jonathan Poole will become CFO on January 1, 2027, and former Amgen executive Jasper van Grunsven will join the company to lead its pain franchise and new product planning.

💬 🔗

WS Investor 09-01-26

Vertex Pharmaceuticals Stock Rises 2.2% After Strong Q2 Results and Higher Revenue Guidance

Vertex Pharmaceuticals (NASDAQ: VRTX) shares rose 2.2% on Tuesday after the biotechnology company reported strong second-quarter results, raised its full-year revenue guidance and highlighted continued progress across both its commercial portfolio and late-stage pipeline.

Second-quarter revenue increased 12% year over year to $3.33 billion, driven by continued strength in its cystic fibrosis (CF) franchise and growing contributions from newer products, including CASGEVY and JOURNAVX. The company also increased its 2026 revenue outlook to $13.1 billion-$13.2 billion from its previous guidance of $12.95 billion-$13.1 billion.

Cystic Fibrosis Business Remains the Growth Engine

Vertex's core CF business continued to deliver solid performance, supported by strong patient demand for ALYFTREK and TRIKAFTA. U.S. revenue increased 11% to $2.06 billion, while international revenue rose 14% to $1.28 billion as ALYFTREK adoption expanded across global markets and CASGEVY infusions continued to grow.

Management expects non-CF products, primarily CASGEVY and the recently launched acute pain treatment JOURNAVX, to generate at least $500 million in revenue during 2026, reflecting the company's ongoing diversification beyond its traditional CF franchise.

Pipeline Expansion and Crinetics Acquisition Strengthen Outlook

Vertex continued advancing its pipeline, with povetacicept remaining on track for a November 30 PDUFA date. The company also announced its planned acquisition of Crinetics Pharmaceuticals, expected to close during the third quarter, adding rare endocrine diseases as a fifth major therapeutic pillar.

CEO Reshma Kewalramani said the company's expanding commercial portfolio and pipeline position Vertex to deliver additional innovative therapies while creating long-term shareholder value.


Strong Balance Sheet Supports Growth Strategy

Vertex ended the quarter with $13.6 billion in cash, cash equivalents and marketable securities, up from $12.3 billion at year-end, supported by strong operating cash flow. The company continued investing in commercial launches and pipeline development while repurchasing shares under its existing buyback program.

What to Watch

Investors will be watching the continued global rollout of ALYFTREK, commercial adoption of CASGEVY and JOURNAVX, the upcoming FDA decision on povetacicept, and the expected completion of the Crinetics acquisition. Markets will also monitor whether Vertex can continue expanding beyond cystic fibrosis while maintaining its strong revenue growth and profitability.

💬 🔗

European Investor 08-04-26

Vertex Pharmaceuticals Slips 1% in Pre-Market After Solid Q1 Results

May 5, 2026

Vertex Pharmaceuticals (Nasdaq: VRTX) edged lower by about 1% in Tuesday's pre-market session following the release of its first quarter 2026 earnings report after Monday's close. The modest decline appears to reflect a market that found the results solid but not surprising — a steady, well-managed business delivering in line with expectations rather than a dramatic beat.

Q1 by the Numbers

Total revenue came in at $2.99 billion, an 8% increase compared to the first quarter of 2025. Growth was driven by the continued strength of the company's cystic fibrosis portfolio alongside a meaningful contribution from newer products. In the U.S., revenue rose 7% to $1.78 billion, supported by strong demand for ALYFTREK, higher net prices across CF therapies, and early contributions from CASGEVY and JOURNAVX. Outside the U.S., revenue grew 9% to $1.21 billion, helped in part by favorable foreign exchange movements.

CEO Reshma Kewalramani highlighted that CASGEVY and JOURNAVX together accounted for more than 25% of the company's quarterly growth, calling it a sign of a revenue base that is becoming increasingly diversified beyond cystic fibrosis.

GAAP net income for the quarter was $1.0 billion, up sharply from $646 million in the same period a year ago — though that comparison is flattered by a $379 million intangible asset impairment charge that weighed on Q1 2025 results. Non-GAAP net income came in at $1.1 billion, up $93 million year-over-year. Cash and marketable securities grew to $13.0 billion as of March 31, compared to $12.3 billion at the end of 2025.

Guidance Unchanged

Vertex reiterated its full year 2026 financial guidance without revision, targeting total revenue of $12.95 billion to $13.1 billion. Non-CF product revenue is expected to reach at least $500 million. The company maintained its combined non-GAAP R&D and SG&A expense guidance of $5.65 to $5.75 billion and a non-GAAP effective tax rate of 19.5% to 20.5%.

The unchanged guidance may be one reason the stock is seeing mild selling pressure. In a market that rewards upward revisions, reiterating prior forecasts — even strong ones — can read as a lack of near-term catalysts.

Pipeline Progress

On the pipeline front, Vertex completed a rolling BLA submission for povetacicept, seeking U.S. accelerated approval in IgA nephropathy following positive Phase 3 interim data. The company also initiated a Phase 3 study in primary membranous nephropathy and a Phase 2 study in generalized myasthenia gravis — moves that signal the company is serious about building a fourth franchise in nephrology alongside CF, gene therapy, and pain.

The FDA recently approved label extensions for both ALYFTREK and TRIKAFTA, making approximately 800 more CF patients in the U.S. eligible for treatment for the first time. Additionally, Vertex submitted for U.S. approval of CASGEVY in children ages 5 to 11 with sickle cell disease or transfusion-dependent beta thalassemia, receiving a Commissioner's National Priority Voucher indicating an accelerated review timeline.

JOURNAVX, the company's first-in-class non-opioid pain medication launched in March 2025, surpassed one million total prescriptions filled, with more than 350,000 filled in Q1 alone. Vertex recorded $29 million in JOURNAVX revenue for the quarter and recently secured Medicare Part D coverage adding approximately 10 million lives.

The Bigger Picture

Vertex is not a company in crisis — far from it. It has a dominant position in cystic fibrosis, a growing gene therapy business, and a pain franchise gaining meaningful traction. The mild pre-market dip likely reflects the absence of a positive guidance revision rather than any fundamental concern. For long-term investors, the pipeline news — particularly around povetacicept in nephrology — may prove to be the most significant takeaway from the quarter.

💬 🔗

The Investor 05-05-26

Vertex to Announce First Quarter 2026 Financial Results on May 4th

💬 🔗

Global Finance News 04-07-26

Vertex Pharmaceuticals reported new Phase 4 study data showing its non-opioid pain drug JOURNAVX enabled opioid-free recovery in most patients following aesthetic and reconstructive surgeries.

In the study of 99 patients, 90.9% remained opioid-free for up to 14 days after surgery when JOURNAVX was used as part of multimodal pain treatment with medicines such as acetaminophen and ibuprofen. About 90.7% of patients rated the treatment’s effectiveness as excellent, very good, or good.

The company said the results highlight the drug’s potential to support opioid-free pain management after surgery. The findings will be presented at the American Academy of Pain Medicine’s PainConnect 2026 meeting.

Business Wire

💬 🔗

Global Finance News 03-06-26

Vertex Pharmaceuticals reported strong fourth quarter and full-year 2025 results, supported by growth in its cystic fibrosis (CF) franchise and contributions from newer products.

In Q4 2025, total revenue rose 10% year over year to $3.19 billion. U.S. revenue increased 12% to $2.06 billion, driven by strong CF demand, including ALYFTREK, and contributions from CASGEVY and JOURNAVX. International revenue grew 5% to $1.13 billion. GAAP net income was $1.2 billion, up from $913 million in Q4 2024.

For full-year 2025, revenue increased 9% to $12.0 billion, with U.S. revenue up 13% to $7.55 billion and international revenue up 3% to $4.45 billion. GAAP net income reached $4.0 billion, compared to a net loss in 2024, reflecting higher product revenue and the absence of large Alpine acquisition-related charges from the prior year. Vertex ended 2025 with $12.3 billion in cash and marketable securities.

For 2026, the company expects total revenue of $12.95–$13.1 billion, including at least $500 million from non-CF products such as CASGEVY and JOURNAVX. Vertex also remains on track to complete a BLA filing for U.S. accelerated approval of povetacicept in IgA nephropathy in the first half of 2026.

Business Wire

💬 🔗

WS Investor 02-13-26

Vertex Unveils First CASGEVY Data in Children 5–11 and Plans Global Regulatory Filings for 2026

Vertex presented the first clinical data showing that CASGEVY, its CRISPR-based gene-editing therapy, produced strong and durable benefits in children ages 5–11 with severe sickle cell disease or transfusion-dependent beta thalassemia. All evaluable young patients met key endpoints: sickle cell patients remained free of vaso-occlusive crises for at least 12 months, and thalassemia patients achieved transfusion independence. Safety findings were consistent with expectations from myeloablative conditioning and transplant. Longer-term results in patients 12 and older continued to show sustained remission and transfusion independence. Vertex plans to begin global regulatory submissions for the 5–11 age group in the first half of 2026.

💬 🔗

Global Finance News 12-07-25

Vertex delivers 11% revenue growth in Q3, raises 2025 revenue outlook to up to $12 billion

Vertex Pharmaceuticals (Nasdaq: VRTX) reported third-quarter 2025 revenue of $3.08 billion, up 11% year over year, driven by continued strength in cystic fibrosis (CF) therapies, including ALYFTREK, and early sales from new launches CASGEVY and JOURNAVX. U.S. revenue grew 15% to $1.98 billion, while international revenue rose 4% to $1.10 billion. GAAP net income reached $1.1 billion, and non-GAAP net income was $1.2 billion, reflecting strong product demand and disciplined expense management.

The company refined its full-year 2025 guidance, now expecting total revenue of $11.9–$12.0 billion and combined non-GAAP R&D, AIPR&D, and SG&A expenses of $5.0–$5.1 billion. Vertex also lowered its non-GAAP effective tax rate forecast to 17–18% due to one-time R&D tax benefits.

CEO Dr. Reshma Kewalramani highlighted progress in the R&D pipeline, including five programs in pivotal development, full enrollment in the Phase 3 IgAN trial for povetacicept, and plans to submit the first module of its Biologics License Application to the FDA by year-end. Vertex ended the quarter with $12 billion in cash and marketable securities, up from $11.2 billion at the end of 2024.

💬 🔗

The Investor 11-04-25

Vertex Highlights New Data on Cystic Fibrosis Treatments at NACFC 2025

Vertex Pharmaceuticals (Nasdaq: VRTX) presented new clinical data at the North American Cystic Fibrosis Conference (NACFC) in Seattle, showcasing the benefits of its CFTR modulators, including the latest therapy ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor).

The studies show that reductions in sweat chloride (SwCl) — a marker of improved CFTR function — correlate with better outcomes in cystic fibrosis (CF) patients, particularly children. In Phase 3 trials, ALYFTREK achieved greater sweat chloride reduction than TRIKAFTA, suggesting stronger potential improvements in lung function and quality of life.

Post-hoc analyses found fewer pulmonary exacerbations and hospitalizations for patients treated with ALYFTREK compared to TRIKAFTA. Data also confirmed that starting modulator therapy earlier in childhood yields broader clinical benefits, including better lung health and nutrition.

💬 🔗

The Investor 10-23-25

Load More

02-24-25WS News

NYSE:LHXFollow

Track all markets on TradingView - Prices are not updated in real time

L3Harris Receives $36 Million U.S. Army SATCOM Order for C2NOW Program

L3Harris Technologies (NYSE: LHX) received a $36 million order from the U.S. Army for its Hawkeye 4 Lite satellite communications terminals, supporting the military’s Command and Control Network Optimized for Warfighting, or C2NOW, initiative.

The terminals are designed to strengthen secure satellite communications interoperability between U.S. forces and NATO partners while providing rapidly deployable communications capabilities for field operations.

The Army configuration will use L3Harris’ Hawkeye 4 Lite terminal, which features field-swappable components intended to provide greater flexibility in changing operational environments.

The system is a portable satellite communications platform designed to support high-speed data, voice, video and command-and-control applications. Its deployment under C2NOW supports the Army’s broader effort to modernize battlefield communications and improve resilient networking across deployed forces.

The order adds to L3Harris’ recent activity supporting Army command-and-control modernization, including multiple communications and networking programs aimed at improving connectivity across increasingly distributed battlefield environments.

💬 🔗

The Investor 11-03-26

L3Harris Invests More Than $100 Million to Expand Liquid Propulsion Production in California

L3Harris Technologies is investing more than $100 million to expand its Canoga Park facility in Los Angeles, increasing production capacity for critical defense and space propulsion programs.

The self-funded project will add nearly 35,000 square feet of manufacturing and assembly space, marking the site’s largest expansion in more than a decade. The company is also adding modern equipment, automation and new machining capacity, including nine turn mills and two 5-axis mills.

The expansion is intended to support several major programs, including increased propulsion production for the Terminal High Altitude Area Defense system, RS-25 engines used on NASA’s Space Launch System, and the Attitude Control System for the Missile Defense Agency’s Next Generation Interceptor.

L3Harris said the Canoga Park investment supports its broader effort to scale propulsion manufacturing in response to rising defense and space demand. The company is investing billions of dollars across propulsion sites in Alabama, Arkansas, California and Virginia, including construction of about 60 facilities and more than one million square feet of additional manufacturing space.

For L3Harris, the project strengthens capacity in a high-priority segment tied to missile defense, strategic space programs and growing U.S. demand for faster production of critical propulsion systems.

💬 🔗

European Investor 10-08-26

L3Harris Technologies (NYSE: LHX) has received a contract from the Commonwealth of Australia to provide an integrated Command, Control, Communications, Computers and Intelligence (C4I) solution under the LAND 4111 protected mobility vehicle modernization program.

Under the three-year program, L3Harris will design, integrate and install advanced communications systems on selected Command and Troop variants of Australia’s Bushmaster Protected Mobility Vehicle. The work will be carried out at the company’s Indo-Pacific Regional Support Centre in Pinkenba, Queensland.

The upgrade is intended to improve connectivity, interoperability and mission effectiveness for the Australian Defence Force by equipping the vehicles with resilient communications and command-and-control capabilities.

L3Harris said the LAND 4111 contract strengthens its long-standing role in supplying sovereign, mission-critical communications and integrated platform solutions to Australia’s military.

Financial terms of the contract were not disclosed.

💬 🔗

Global Finance News 10-06-26

L3Harris Highlights Advanced Manufacturing Behind WESCAM MX-Series EO/IR Systems

L3Harris Technologies highlighted the manufacturing processes behind its WESCAM MX-Series electro-optical and infrared systems, emphasizing precision, scalability and mission-specific configuration for defense and security customers.

The company said WESCAM manufacturing brings together engineering, production and operations teams throughout the product lifecycle, from component integration and calibration to testing and final acceptance. Digital engineering, streamlined workflows and continuous process improvements are used to support faster delivery while maintaining consistent quality.

A key feature of the MX-Series is its modular architecture, which allows customers to tailor sensor configurations to specific operational requirements and add new capabilities over time without replacing entire systems.

The systems are designed for intelligence, surveillance, reconnaissance and targeting missions across airborne, land and maritime platforms. L3Harris said its approach is informed not only by engineering and manufacturing expertise but also by personnel with experience operating the systems in the field.

The company is continuing to invest in manufacturing capabilities and workforce development as it seeks to scale production of advanced EO/IR systems while maintaining performance and reliability standards.

💬 🔗

WS Investor 10-01-26

L3Harris Wins $6 Billion THAAD Propulsion Contract to Expand Missile Defense Production

L3Harris Technologies has received an undefinitized contract from Lockheed Martin valued at more than $6 billion over seven years to significantly expand propulsion production for the Terminal High Altitude Area Defense system.

The award follows an earlier framework agreement with the U.S. Department of War to quadruple THAAD propulsion production. L3Harris said the contract, together with its recently announced PAC-3 MSE propulsion award, is consistent with previously stated expectations for both programs.

To support the expansion, L3Harris plans to build a new facility dedicated to THAAD Solid Rocket Boost Motor production and increase capacity for Liquid Divert and Attitude Control systems.

THAAD is designed to intercept short-, medium- and intermediate-range ballistic missile threats both inside and outside the atmosphere. L3Harris said the system has maintained a 100% intercept success rate in flight testing since production began.

The contract adds another major long-term propulsion program to L3Harris’ missile portfolio and supports a broader effort to increase U.S. missile defense manufacturing capacity.

The scale of the award also reinforces the company’s role as a key propulsion supplier to Lockheed Martin and the wider U.S. missile defense industrial base.

💬 🔗

WS Investor 09-29-26

L3Harris Completes Design Review for SDA Tranche 3 Missile Tracking Satellites

L3Harris Technologies (NYSE: LHX) completed the Preliminary Design Review for the Space Development Agency’s Tracking Layer Tranche 3 program, advancing development of its next-generation space-based missile warning and tracking system.

The review confirms the baseline design for L3Harris’ Tranche 3 mission solution, which includes satellites, ground systems, networking, communications and infrared payloads. The system is designed to provide infrared sensing, advanced on-orbit data processing and real-time threat detection, supporting near-continuous global tracking of missile threats once deployed.

L3Harris received the SDA contract in December 2025 to design and build 18 spacecraft for the Tranche 3 Tracking Layer. The company said it now has more than 70 missile tracking and defense satellites on order for the Proliferated Warfighter Space Architecture.

The satellites will operate as part of the SDA’s broader layered missile defense architecture and are intended to strengthen detection and tracking of advanced ballistic and hypersonic threats.

💬 🔗

Global Finance News 09-25-26

L3Harris Highlights Expanding Role in Australia’s Maritime Defense

L3Harris Technologies is highlighting its growing role in Australia’s maritime defense strategy as the country faces increasing security demands across the Indo-Pacific.

The company said it has a long history of working with the Royal Australian Navy, Australian Border Force and local industry partners to support maritime operations. Its portfolio in the country includes sonar and underwater systems, communications, electronic warfare and surveillance technologies.

L3Harris emphasized that many of these capabilities are being co-developed with Australian partners rather than simply imported from overseas programs. The systems are intended to support missions ranging from border protection and constabulary operations to high-intensity conflict.

The company is also positioning its local partnerships as part of Australia’s broader effort to strengthen its sovereign defense industrial base. L3Harris said its work is aligned with the country’s Defence Industry Development Strategy and is intended to build longer-term domestic capability.

The focus on Australia reflects broader defense demand for undersea warfare, electronic warfare, secure communications and maritime surveillance as governments increase investment in Indo-Pacific security.

💬 🔗

The Investor 09-23-26

L3Harris Expands Modular Electronic Warfare Architecture With AI-Enabled DiSCO

L3Harris is advancing a new modular electronic warfare architecture designed to connect distributed sensors, effectors and platforms across air, ground, maritime and unmanned systems.

The company said its approach moves away from traditional single-function, platform-specific electronic warfare systems toward software-defined, multifunctional systems built on commercial off-the-shelf hardware and open architecture. Capabilities can be updated, swapped or reconfigured in the field, allowing the same system to support defensive operations, offensive missions or intelligence collection.

At the center of the architecture is L3Harris’ Distributed Spectrum Collaboration Operations, or DiSCO, an electromagnetic battle management system developed with cloud providers. DiSCO combines battlefield sensors, data links and communications into a single network and uses artificial intelligence and machine learning to reduce the time required to identify unknown signals from months to minutes.

The company is also deploying its Deceptor electronic warfare payload on unmanned platforms and air-launched effects, extending non-kinetic capabilities to smaller and potentially expendable systems.

The broader strategy reflects growing demand for electronic warfare systems that can be updated quickly, operate across multiple domains and avoid dependence on a single vendor or platform.

💬 🔗

The Investor 09-17-26

L3Harris Pushes KC-135 Avionics Modernization as Tanker Fleet Heads Beyond 2050

L3Harris Technologies (NYSE: LHX) is highlighting its avionics modernization solution for the U.S. Air Force’s KC-135 aerial refueling fleet, which is expected to remain in service beyond 2050. The company says targeted upgrades can extend the aircraft’s operational life while maintaining global mission readiness.

L3Harris’ approach replaces aging flight-deck instrumentation with modern digital technology, aiming to reduce maintenance risk, sustainment costs and aircrew workload. The system uses a government-owned architecture and an established C-135 baseline, providing an open platform for future upgrades while limiting integration risk.

The modernization effort also addresses declining availability of parts for the decades-old aircraft. L3Harris uses commercially proven components and industry-standard interfaces, which the company says can reduce dependence on individual vendors and provide greater flexibility for future upgrades.

L3Harris has previously completed mission-system upgrades for C-135 variants operated by both the U.S. Air Force and the U.K. Royal Air Force, positioning the company to benefit from continued investment in extending the service life of existing military aircraft fleets.

💬 🔗

The Investor 09-15-26

L3Harris Wins $60 Million U.S. Air Force Contract for Proximity Sensors

L3Harris Technologies has received an approximately $60 million contract from the U.S. Air Force to continue production of its DSU-43/B Cockpit Selectable Height of Burst Sensors, or C-HOBS.

The technology allows aircrews to select the precise altitude at which a munition detonates, enabling its effects to be adjusted for different targets and mission environments. The sensors provide radar-guided performance as well as manual and cockpit-selectable burst-height capabilities.

L3Harris said it is increasing production capacity for proximity fuzes and sensors as the U.S. military seeks greater supplies of proven and cost-effective counter-threat technologies. Production of the C-HOBS systems will take place at the company’s Cincinnati facility.

The contract adds to L3Harris’ recent momentum in missile and weapons systems as the company expands manufacturing capacity to meet higher U.S. defense demand. The award also reinforces the role of its Missile Solutions business in supplying critical components for modern munitions.

💬 🔗

WS Investor 09-14-26

Load More

03-20-26The Investor

03-12-26Global Finance News

USFollow

U.S. Job Openings and Factory Orders Beat Forecasts in September

U.S. economic data came in stronger than expected in September, with both job openings and factory orders exceeding market forecasts.

JOLTS job openings rose to 7.523 million, well above the 7.150 million forecast and up from 7.190 million previously. The stronger reading suggests labor demand remained relatively resilient despite signs of gradual cooling elsewhere in the employment market.

Factory orders increased 1.8% month over month, also beating the 1.2% forecast and accelerating sharply from the previous 0.3% increase.

The combination of stronger labor demand and faster factory-order growth points to firmer underlying economic activity than expected. For financial markets, the data may modestly reduce expectations for aggressive Federal Reserve easing, particularly if upcoming employment and inflation indicators also remain strong.

💬 🔗

The Investor 11-03-26

U.S. Stocks Rise as Oil Plunges and ISM Manufacturing Beats Forecasts

U.S. stocks extended gains Monday as sharply lower oil prices eased inflation concerns and stronger-than-expected ISM manufacturing data supported confidence in the economy.

The Dow Jones rose 1.03% to 52,304.31, the Nasdaq gained 0.87% to 25,658.79, and the S&P 500 advanced 0.62% to 7,627.00.

Brent crude fell more than 6% to around $106.41 a barrel. The sharp decline in energy prices provides a favorable backdrop for equities by reducing concerns over fuel-driven inflation and potentially lowering costs for businesses and consumers.

Economic data also offered support. The ISM Manufacturing PMI increased to 55.5 in October, beating the 54.5 forecast and improving from 54.5 previously. The reading remained well above the 50 threshold, indicating continued expansion in U.S. manufacturing activity.

At the same time, the ISM Manufacturing Prices index eased to 75.2 from 77.9 and came in below the 77.2 forecast. Although input-price pressures remained elevated, the decline provided some reassurance on the inflation outlook. Manufacturing employment slipped slightly to 52.4 from 52.7 but remained in expansion territory.

Construction spending was the major weak point, falling 1.9% month over month in September compared with expectations for a 0.4% increase and a previous 2.0% gain.

Overall, the rise in U.S. indexes appears to reflect a combination of sharply lower oil prices, stronger manufacturing activity and some moderation in manufacturing price pressures. The weak construction spending figure limited the otherwise positive macro picture but was not enough to offset the broader improvement in investor sentiment.

💬 🔗

European Investor 11-02-26

U.S. Stocks Trade Mixed as Wider Trade Deficit Offsets Inventory Growth

U.S. stocks were mixed after fresh economic data showed a wider-than-expected goods trade deficit alongside stronger retail inventory growth. The S&P 500 rose 0.15% and the Dow gained 0.27%, while the Nasdaq was nearly unchanged, down 0.01%.

The U.S. goods trade deficit widened to $134.90 billion in September, larger than the $130.40 billion consensus estimate and the previous $132.07 billion deficit. The deterioration suggests imports continued to outpace exports and could weigh on the trade component of third-quarter GDP calculations.

Retail inventories excluding autos increased 0.4% in September, accelerating from 0.1% previously. Higher inventories can provide some near-term support to GDP, although persistent inventory accumulation can become a negative signal if it reflects weaker-than-expected final demand.

Overall, the releases offered a mixed economic signal: stronger inventory accumulation was offset by a larger trade deficit, helping explain the relatively subdued reaction across major U.S. equity indexes.

💬 🔗

WS Investor 10-28-26

Wall Street Rises as Strong Consumer Confidence Offsets Mixed U.S. Economic Data

U.S. stocks moved higher Tuesday, with the Nasdaq gaining 1.19%, the S&P 500 rising 0.66% and the Dow Jones adding 0.14%, as investors digested a mixed batch of economic data.

Conference Board Consumer Confidence climbed to 91.7 in October, well above the 81.2 forecast and up from 84.2 previously. The stronger-than-expected reading pointed to improved household sentiment and provided the clearest positive signal from the day’s releases.

New home sales also came in better than expected at an annualized 676,000 in September, compared with the 651,000 forecast, although sales edged down from 680,000 previously.

Other indicators were softer. Building permits slipped to 1.398 million, slightly below the 1.400 million forecast and 1.403 million prior reading. Weekly ADP employment growth slowed to 16,800 from 18,500, suggesting some moderation in private-sector hiring.

Durable goods orders rose 1.8% in September, a sharp improvement from the prior 0.1% increase but slightly below the 2.0% consensus estimate.

Overall, the data presented a mixed economic picture, with stronger consumer confidence and housing demand offsetting softer employment and building activity. The stronger move in the Nasdaq suggests risk appetite remained relatively firm despite the uneven macro signals.

💬 🔗

European Investor 10-27-26

Wall Street Falls as Mixed Jobless Claims and Surging Oil Keep Rate and Inflation Concerns in Focus

U.S. stocks traded lower after the latest labor-market data sent a mixed signal while a sharp rise in crude oil added to inflation concerns.

Initial jobless claims fell to 194,000, better than the 200,000 consensus estimate and down from 200,000 previously. The reading suggests layoffs remain relatively contained and the labor market is still holding up.

Continuing jobless claims, however, rose to 1.728 million, above the 1.720 million forecast and up from 1.703 million previously. That points to some difficulty for unemployed workers in finding new jobs even as new layoffs remain low.

Equities were under pressure, with the S&P 500 down about 0.78%, the Dow Jones Industrial Average off 0.15%, and the Nasdaq falling roughly 1.42%. The heavier Nasdaq decline suggests continued pressure on rate-sensitive growth and technology stocks.

At the same time, Brent crude climbed about 2.4% to $111.48 per barrel. Higher oil prices can complicate the inflation outlook by increasing energy and transportation costs, potentially reinforcing concerns that the Federal Reserve may need to keep monetary policy restrictive for longer.

Overall, the combination of resilient initial claims and rising oil prices appears to be weighing on risk appetite, even as the increase in continuing claims points to some underlying softening in the labor market.

💬 🔗

WS News 10-22-26

Wall Street Trades Mixed as Hotter PPI and Strong Retail Sales Reinforce Rate Concerns

U.S. stocks traded mixed after a batch of economic data showed stronger consumer spending, hotter producer inflation and continued labor-market resilience. The S&P 500 fell 0.26% to 7,698.99 and the Nasdaq dropped 0.86% to 26,463.05, while the Dow Jones Industrial Average rose 0.55% to 51,907.65.

September retail sales increased 0.8% month over month, well above the 0.3% consensus estimate, although growth slowed from 1.3% previously. Core retail sales rose 0.9%, also beating the 0.6% forecast but easing from 1.4%.

Inflation data were more concerning. Producer prices jumped 1.3% month over month, more than double the 0.6% expected and sharply above the prior 0.5% increase. Core PPI rose 0.7%, compared with a 0.3% forecast and 0.2% previously.

The labor market remained firm. Initial jobless claims were 199,000, matching expectations and little changed from 198,000, while continuing claims came in at 1.710 million, exactly in line with forecasts and slightly below 1.714 million previously.

Manufacturing data were also much stronger than expected, with the New York Empire State Manufacturing Index jumping to 25.5 in October from 7.6, far above the 12.1 consensus estimate.

The data combination points to an economy that remains resilient but is also experiencing renewed inflation pressure. That backdrop may reinforce expectations for interest rates to remain elevated for longer, which appears to be weighing particularly on the rate-sensitive Nasdaq even as the Dow moves higher.

💬 🔗

The Investor 10-15-26

Wall Street Falls as September Inflation Comes in Hotter Than Expected

U.S. stocks moved lower after September inflation data showed broader price pressures remained firmer than economists expected. The S&P 500 fell 0.76% to 7,745.85, while the Nasdaq dropped 0.99% to 26,934.31. The Dow Jones Industrial Average declined 0.14% to 51,597.18.

Headline CPI increased 0.6% month over month in September, matching expectations but accelerating from 0.4% in August. On a year-over-year basis, inflation rose to 3.7%, above the 3.6% consensus estimate and up from 3.4% previously.

More importantly for the Federal Reserve outlook, core inflation also came in hotter than expected. Core CPI rose 0.3% month over month versus the 0.2% forecast, while the annual core rate accelerated to 2.6% from 2.4%, also exceeding the 2.5% consensus estimate.

The combination of higher headline inflation and an upside surprise in core prices suggests underlying inflation pressures remain persistent. That could reduce expectations for near-term monetary easing or reinforce the case for keeping interest rates elevated for longer.

The Nasdaq’s larger decline is consistent with renewed rate concerns weighing more heavily on growth and technology stocks, while the relatively smaller move in the Dow suggests a more defensive market response.

💬 🔗

Global Finance News 10-14-26

Wall Street Trades Mixed as U.S. Housing Data Beats Expectations

U.S. stocks traded mixed Tuesday as investors digested stronger-than-expected housing data alongside another increase in weekly private-sector employment.

The S&P 500 slipped 0.07% to 7,801.82, while the Nasdaq Composite fell 0.11% to 27,217.00. The Dow Jones Industrial Average was slightly higher, gaining 0.04% to 51,868.87.

U.S. existing home sales increased to an annualized 3.99 million units in September, above expectations of 3.95 million and up from 3.93 million previously. On a monthly basis, sales rose 1.5%, significantly stronger than the expected 0.8% decline and reversing the previous month’s 3.2% drop.

Separately, ADP’s weekly employment measure showed private payrolls increasing by 24,800, up from 23,800 in the previous reading.

The data points to continued resilience in parts of the U.S. economy, particularly housing and employment. However, the relatively muted equity-market reaction suggests investors remain cautious about how stronger economic activity could influence the Federal Reserve’s interest-rate outlook.

💬 🔗

European Investor 10-13-26

U.S. Consumer Sentiment Weakens in October as Inflation Expectations Stay Elevated

The University of Michigan’s preliminary Consumer Sentiment Index fell to 46.3 in October, below the 47.5 consensus estimate and down from 48.1 previously.

Consumer expectations were somewhat more resilient, rising to 47.3 from 46.3 and beating the 45.9 forecast. That suggests households became slightly less pessimistic about the outlook even as overall sentiment deteriorated.

One-year inflation expectations edged up to 4.7% from 4.6%, although the reading came in slightly below the 4.8% consensus estimate.

The report gives a mixed signal for markets. Softer headline sentiment points to continued caution among U.S. consumers, while the improvement in expectations offers some support to the growth outlook. However, inflation expectations remain elevated, which could keep investors sensitive to additional price-pressure data and complicate expectations for faster monetary easing.

💬 🔗

WS News 10-09-26

U.S. Stocks Edge Higher as Brent Crude Holds Near $104

U.S. stocks opened modestly higher on Thursday, with the S&P 500 up 0.27% at 7,786.27, the Dow Jones Industrial Average gaining 0.28% to 51,375.78, and the Nasdaq rising 0.34% to 27,285.85.

Brent crude was trading at $103.89 per barrel, down 0.37% on the day, after moving between roughly $102.50 and $103.90 during the session. Oil remains at elevated levels despite the slight decline.

The combination of firm equity markets and Brent holding above $100 suggests investors are balancing resilient risk appetite against continued inflation concerns from high energy prices. Elevated crude can increase transportation and input costs across the economy, potentially keeping some pressure on headline inflation.

For equities, the near-term question is whether oil prices stabilize around current levels or resume their recent rise. A renewed move higher in crude could revive concerns over inflation and interest rates, while a pullback would provide some relief to broader market sentiment.

💬 🔗

Global Finance News 10-09-26

Load More

10-19-26WS News

10-15-26The Investor

10-09-26Global Finance News

10-09-26Global Finance News

10-08-26European Investor

NYSE:SYYFollow

Track all markets on TradingView - Prices are not updated in real time

Sysco Falls 4.3% as Softer Sales Outlook and Cost Pressures Offset Solid Q1 Results

Sysco (NYSE: SYY) shares fell about 4.3% after the company reported modest first-quarter fiscal 2027 growth but indicated that full-year sales are now expected at the lower end of its previous range.

Quarterly sales increased 2.8% to $21.7 billion, while U.S. Foodservice volume rose 2.6% and local volume increased 2.7%. Gross profit grew 3.8% to $4.1 billion, with gross margin expanding 18 basis points to 18.6%.

Adjusted operating income increased 3.2% to $927 million, adjusted net earnings rose 4.2% to $574 million and adjusted EPS increased 3.5% to $1.19. Adjusted EBITDA rose 5.4% to $1.1 billion.

However, GAAP operating income fell 10.4% to $717 million as acquisition-related costs tied to the planned Jetro Restaurant Depot transaction weighed on results. Operating expenses increased 7.5%, reflecting acquisition costs, higher volumes and investment in growth initiatives.

Management reiterated its fiscal 2027 adjusted EPS growth target of 9%-11% and maintained its local volume growth assumption of about 2.5%. But full-year sales growth is now expected at the lower end of the previous 6%-7% range because food-cost inflation has been weaker than anticipated.

The operating environment also remains uneven. Sysco cited continued softness in restaurant traffic, higher-than-expected fuel costs and lower food inflation as headwinds, although management expects AI-driven efficiency initiatives to deliver roughly $100 million of savings during the year.

The 4.3% decline appears to reflect disappointment with the softer sales outlook and relatively modest adjusted earnings growth. While volumes and margins improved, investors appear to be focusing on slower nominal revenue growth, elevated costs and the limited near-term earnings acceleration implied by the first-quarter results.

💬 🔗

The Investor 11-03-26

Sysco Secures $750 Million Loan Facility to Help Fund JRD Acquisition

Sysco (NYSE: SYY) has established a $750 million senior unsecured delayed-draw term loan facility, with proceeds expected to help finance its previously announced acquisition of JRD Unico and Warehouse Realty.

The facility consists of two $375 million tranches, with maturities of six and eight years. Sysco can draw the funds in multiple advances during the one-year period following the amendment. The financing was arranged with CoBank and lenders under Sysco’s existing revolving credit agreement, with Bank of America serving as administrative agent.

Sysco said the proceeds can be used for general corporate purposes, including acquisitions, and intends to use the financing partly for the cash consideration and transaction expenses associated with the JRD deal.

Sysco Prepares Management for Integration

The company also approved performance-based retention awards tied to the transaction. CEO Kevin Hourican received a $2 million target PSU award, while interim CFO Brandon Sewell received a $1 million award. The awards are contingent on the acquisition closing, currently anticipated by the third quarter of 2027.

Sysco separately granted a $700,000 cash award to its chief human resources officer in connection with leadership of the company’s AI-efficiency and AI-driven business transformation initiatives.

💬 🔗

The Investor 09-06-26

Sysco reported second-quarter fiscal 2026 results showing steady top-line growth and improving underlying momentum. Sales rose 3.0% to $20.8 billion, supported by positive U.S. local volume growth of 1.2%, while gross profit increased 3.9% to $3.8 billion as margins expanded despite ongoing food cost inflation.

Although reported operating income and EPS declined modestly year over year, adjusted results improved, with adjusted EPS up 6.5% to $0.99 and adjusted operating income up 3.1%. Management cited sequentially improving local case growth and stronger execution across key initiatives, prompting Sysco to raise expectations toward the high end of its full-year adjusted EPS guidance range of $4.50–$4.60 and reaffirm confidence in delivering long-term earnings growth.

💬 🔗

European Investor 01-27-26

Sysco (NYSE: SYY) Q1 FY2026: sales up, adjusted profit rises despite higher costs

Sysco reported fiscal first-quarter 2026 sales of 21.1 billion dollars, up 3.2 percent year over year, as U.S. Foodservice volume inched up 0.1 percent. Gross profit grew 3.9 percent to 3.9 billion dollars, driven by pricing and sourcing efficiencies, lifting gross margin by 13 basis points to 18.5 percent. Reported operating income slipped 1 percent to 800 million dollars, while adjusted operating income rose 2.9 percent to 898 million dollars. Net earnings declined 2.9 percent to 476 million dollars, but adjusted net income increased 2 percent to 551 million dollars; adjusted EPS climbed 5.5 percent to 1.15 dollars.

In the U.S. Foodservice segment, sales rose 2.9 percent to 14.8 billion dollars, with adjusted operating income down 1 percent to 916 million dollars. International operations performed strongly, with sales up 4.5 percent (7.9 percent excluding the Mexico JV divestiture) and adjusted operating income up 13 percent to 147 million dollars, helped by margin expansion to 20.8 percent.

Sysco ended the quarter with 844 million dollars in cash and 3.5 billion dollars in liquidity. Free cash flow was negative 50 million dollars, and 259 million dollars was returned to shareholders via dividends. The company reaffirmed full-year guidance for sales growth of 3–5 percent and adjusted EPS growth of 1–3 percent (or about 5–7 percent excluding last year’s lower incentive comp). CEO Kevin Hourican said Sysco is seeing strong local business momentum and expects continued margin expansion through fiscal 2026.

💬 🔗

WS Investor 10-28-25

Sysco Corporation reported solid financial results for its second fiscal quarter of 2025, ending December 28, 2024. Sales increased by 4.5%, with U.S. Foodservice volume rising by 1.4%. Gross profit grew 3.9% to $3.7 billion, while operating income rose 1.7% to $712 million. Adjusted operating income saw a stronger increase of 5.1% to $783 million. EBITDA grew 1.9% to $931 million, with adjusted EBITDA increasing 4.4% to $969 million. Earnings per share (EPS) remained steady at $0.82, while adjusted EPS increased 4.5% to $0.93.

The company highlighted particularly strong performance in its International segment, which achieved a 14.5% rise in operating income and a 26.5% increase in adjusted operating income. Sysco also noted progress in its local business, including improvements in new customer acquisitions and Net Promoter Scores. Investments in sales professionals and specialty offerings are expected to further enhance local case volume performance in the second half of fiscal 2025.

Sysco reiterated its fiscal year 2025 guidance, forecasting sales growth of 4%-5% and adjusted EPS growth of 6%-7%. The company also increased its planned cash returns to shareholders to $2.25 billion, with share repurchases raised to $1.25 billion (up from $1 billion) and dividends set at $1 billion. CEO Kevin Hourican emphasized confidence in achieving full-year goals, while CFO Kenny Cheung highlighted the company's focus on driving operating leverage, margin expansion, and shareholder returns.

💬 🔗

WS Investor 01-28-25

Load More

NASDAQ:GOOGFollow

Track all markets on TradingView - Prices are not updated in real time

Alphabet Q3 Revenue Jumps 25% as Google Cloud Growth Surges on AI Demand

Alphabet (NASDAQ: GOOG, GOOGL) reported a strong third quarter of 2026, with revenue rising 25% year over year to $127.6 billion, marking its 13th consecutive quarter of double-digit growth.

Google Services revenue increased 11% to $96.3 billion. Google Search & other revenue rose 12% to $63.4 billion, with management saying year-over-year Search query growth reached its fastest pace in five years. YouTube advertising revenue increased to $11.2 billion from $10.3 billion.

Google Cloud was the standout performer, with revenue more than doubling to $30.7 billion from $15.2 billion. Growth was driven by enterprise AI infrastructure, AI solutions, core Google Cloud Platform services and TPU systems. Cloud operating income surged to $11.1 billion from $3.6 billion.

Alphabet’s operating income increased 30% to $40.6 billion, with operating margin improving to 31.8%. However, net income fell to $26.2 billion from $35.0 billion, while diluted EPS declined to $2.12 from $2.87, largely reflecting an $8.2 billion net other expense compared with $12.8 billion of other income a year earlier.

AI adoption continued to accelerate. Alphabet said its first-party model APIs are processing nearly 32 billion tokens per minute, more than four times the year-ago level, while the Gemini app has surpassed one billion users.

Overall, the quarter showed exceptionally strong momentum in Google Cloud and continued resilience in Search, with AI investment translating into faster revenue growth and sharply higher cloud profitability despite the year-over-year decline in reported net income.

💬 🔗

Global Finance News 11-01-26

Google Launches Workplace AI Agent That Acts Like Colleague

💬 🔗

WS News 10-08-26

Meta’s Muse Could Be the Biggest Threat Google Has Faced in 20 Years

Meta’s Muse could challenge Google’s $63 billion Search business by replacing searches, clicks, and ads with AI-driven decisions and transactions.

(finance.yahoo.com)

💬 🔗

WS News 09-28-26

Accenture and Google Cloud Team With Volvo Cars on AI-Powered Automotive Software Platform

Accenture and Google Cloud said Volvo Cars has become the lead industry partner for Horizon, an open-source software development platform designed to help automakers build, test and deploy Android Automotive OS software faster.

Volvo Cars is migrating its global AAOS development environment to Horizon, which combines cloud-native development tools, virtual testing environments and AI-assisted workflows. The platform is intended to shorten development cycles and give engineering teams more time to focus on in-car digital experiences.

Accenture and Google Cloud said Horizon can deliver up to 9x faster software testing using virtual Android Automotive environments, reduce infotainment feature development costs by up to 40%, and cut build feedback times from as much as two hours to minutes. The platform also supports remote access to virtual and physical device farms and faster onboarding through virtual workbenches.

The companies said insights from the Volvo collaboration will help refine Horizon and expand its generative AI capabilities for other automakers and industrial manufacturers. Accenture, Google Cloud and Volvo are already working to extend the platform to additional organizations and markets.

The partnership highlights the growing shift toward software-defined vehicles, where faster development, virtual validation and AI-assisted engineering are becoming increasingly important competitive capabilities.

💬 🔗

Global Finance News 09-22-26

NVIDIA, Google and Emerald AI Launch Alliance to Tackle AI Data Center Power Constraints

NVIDIA, Google and Emerald AI have launched the AI Energy Management Alliance, a new coalition aimed at making large AI data centers more flexible in how they consume electricity and accelerating their connection to power grids.

Power availability has become a major constraint on the expansion of U.S. AI infrastructure. The alliance is developing a framework that would allow AI data centers to adjust electricity consumption according to grid conditions by shifting computing workloads, using energy storage or paired generation, and reducing demand during periods of system stress.

The approach could allow utilities to connect large AI facilities more quickly while reducing the need for costly grid upgrades. AEMA plans to establish standardized performance requirements covering response times, power curtailment, emergency operations and data sharing between data centers and grid operators.

The initiative brings together AI companies, data center operators, power producers, utilities and grid operators. For NVIDIA and the broader AI industry, addressing electricity constraints is becoming increasingly important as rapidly expanding AI computing capacity requires substantially more power infrastructure.

💬 🔗

WS Investor 09-16-26

European antitrust rulings reshape Google’s comparison shopping ecosystem | Noah Intelligence

New regulations and legal challenges are disrupting Google's dominance in comparison shopping services across Europe, prompting calls for increased fairness among merchants and rivals.A comparison shopping service, or...

(noah-news.com)

💬 🔗

WS Investor 09-14-26

Regulators target transparency in digital ad auctions amid Google and Amazon cases | Noah Intelligence

Recent legal actions against Google and Amazon spotlight growing concerns over auction fairness and transparency in digital advertising, raising questions about platform control and trust.The latest legal scrutiny of...

(noah-news.com)

💬 🔗

The Investor 09-12-26

Alphabet (GOOGL) Stock Edges Higher After Morgan Stanley Raises Price Target

Alphabet (NASDAQ: GOOGL) shares traded modestly higher on Tuesday after Morgan Stanley raised its price target on the Google parent company, reinforcing confidence in its long-term growth prospects driven by artificial intelligence and digital advertising.

The brokerage maintained its Overweight rating while increasing its price target to $415 from $375, signaling continued optimism about Alphabet's ability to capitalize on AI-driven opportunities across its search, cloud, and software businesses.

# Morgan Stanley Sees More Upside

The higher price target reflects growing confidence that Alphabet will continue benefiting from expanding AI adoption while maintaining its leadership in digital advertising.

Analysts also remain constructive on the company's cloud business, where ongoing investment in generative AI services is expected to support revenue growth and margin expansion over the coming years.

# AI Remains a Key Growth Driver

Alphabet has accelerated the rollout of AI-powered products across Google Search, Google Cloud, and Workspace, while continuing to invest heavily in infrastructure to support growing enterprise and consumer demand.

The company's strong balance sheet and leadership in AI innovation continue to position it as one of the largest beneficiaries of the industry's long-term growth.

# Why GOOGL Stock Was Little Changed

Despite the higher price target, Alphabet shares posted only modest gains, suggesting much of the positive outlook may already be reflected in the stock's valuation.

Still, Morgan Stanley's decision to reaffirm its Overweight rating while lifting its valuation target reinforces Wall Street's confidence in Alphabet's long-term earnings potential and competitive position within the AI ecosystem.

💬 🔗

Global Finance News 06-30-26

Alphabet Falls 5% Despite Citi Reiterating Positive Rating

Alphabet (NASDAQ: GOOG) fell 5% even after Citigroup reiterated its Market Outperform rating, as investors reacted to broader concerns surrounding competition, valuation, and the evolving artificial intelligence landscape.

The decline came despite Citi maintaining a positive long-term view on the company. Alphabet remains one of the world's dominant digital advertising and cloud computing platforms, with growing exposure to artificial intelligence through products such as Gemini and its expanding AI infrastructure investments.

However, investor sentiment toward the stock has recently become more cautious as competition in AI-powered search intensifies. Market participants continue to evaluate how generative AI could reshape internet search and digital advertising, two of Alphabet's most important businesses.

Despite the sharp decline, analysts generally remain constructive on Alphabet's outlook. The company's leadership positions in search, cloud computing, digital advertising, and artificial intelligence continue to provide multiple growth drivers. Google Cloud has also emerged as a key beneficiary of growing enterprise AI adoption, helping diversify revenue beyond advertising.

Citigroup's reaffirmed Market Outperform rating suggests the firm believes the recent weakness does not alter Alphabet's long-term investment case. Nevertheless, the stock's decline highlights that investors remain sensitive to competitive developments and AI-related execution risks across the technology sector.

💬 🔗

Global Finance News 06-22-26

Alphabet Holds Steady as TD Cowen Raises Price Target to $475

Alphabet (GOOG) traded little changed despite receiving a bullish analyst update from TD Cowen, which raised its price target to $475 from $450 while maintaining a Buy rating.

The higher target reflects growing confidence in Alphabet's ability to capitalize on the artificial intelligence boom while maintaining the strength of its core Search and advertising businesses. Investors have become increasingly optimistic that Google's AI investments are beginning to translate into stronger product offerings, improved user engagement, and new monetization opportunities across Search, Cloud, YouTube, and Workspace.

The lack of a significant stock reaction suggests that investors had already been expecting positive analyst commentary following the company's recent execution and strong positioning within the AI ecosystem. Alphabet has been one of the major beneficiaries of increasing enterprise AI adoption, particularly through Google Cloud, which continues to gain traction among businesses deploying large-scale AI workloads.

Analysts remain focused on several key catalysts, including the pace of Google Cloud growth, AI-driven improvements in Search, expansion of advertising revenue, and the company's ability to convert its massive AI investments into sustainable earnings growth.

While the stock was flat on the day, the target increase reinforces the view that many Wall Street firms continue to see substantial upside potential in Alphabet. With the new $475 target standing well above the current share price, TD Cowen's update suggests confidence that Alphabet's combination of AI leadership, dominant digital advertising position, and growing cloud business can continue to drive long-term shareholder returns.

💬 🔗

Global Finance News 06-09-26

Load More

11-03-26Global Finance News

10-26-26Global Finance News

10-08-26The Investor

10-07-26European Investor

10-06-26The Investor